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Abstract 
Members of the genus of Aristolochia have been used as medicines both in the 
Orient and the West. However, nephrotoxic response to several Aristolochia species was 
revealed in recent decades. Aristolochic acid, a known nephrotoxic and carcinogenic 
agent, was suspected to be the bioactive compound responsible for the toxic effects. Two 
renal diseases, the BaDcan endemic nephropathy (BEN) and Chinese herbs nephropathy 
(CHN), have been traced to Aristolochia species. This project was designed to 
investigate the toxicity of two Chinese herbs: Guan-mu-tong 關木通 (Caulis 
Aristolochiae Manshuriensis) and Ma-dou-ling 馬究铃 (Fructus Aristolochiae). 
These two herbs are derived from the stem of Aristolochia manshuriensis and the fruit of 
A. debilis or A. contorta, respectively. 
la the present study, aqueous extracts of Guan-mu-tong and Ma-dou-ling were 
used in the acute, subchronic and reproductive toxicity tests. The results from the toxicity 
tests showed that Ma-dou-ling had a higher toxicity than Guan-mu-tong. Li acute toxicity 
test, no lethal dose could be determined for Guan-mu-tong as even the highest possible 
dosage (337.72 g/kg i.g.) did not cause 100 % mortality in mice, whereas L D 5 0 of Ma-
dou-ling with 95 % confidence limit was found to be 64.74土1.22 g/kg i.g. The cause of 
death in acute toxicity of Ma-dou-ling was probably acute renal failure. For the 3-month 
subchronic toxicity test, Guan-mu-tong did not exert any toxic effects on female rats 
while Ma-dou-ling caused damages to the kidney, liver and forestomach. Urinalysis 
revealed an elevated urine volume, urinary protein contents and glucose contents in the 
V 
treatment groups of Ma-dou-ling. A raised serum alanine aminotransferase activity was 
found in the 10 gy^ :g i.g. group of Ma-dou-ling after 1.5- and 3-month subchronic test. 
Papillomas and carcinomas with metastasis were found in the 4 and 10 g/kg i.g. groups 
after the 3-month subchronic test of Ma-dou-ling. Reproductive toxicity tests revealed 
that Guan-mu-tong had a mild effect on the fertility rate in mice while Ma-dou-ling 
exerted at a relative lower dosage, a 100 % anti-fertility effect at 19.2 g/kg i.g. 
Quantitative analysis with high performance liquid chromatography showed a higher 
content of aristolochic acid in the aqueous extract of Ma-dou-ling (about 459 \x.^ g of 
crude drug) than that in Guan-mu-tong (about 66 ^g/g of crude drug). The lower 
aristolochic acid content in the latter may account for the relatively lower toxicity in the 
three toxicity tests. 
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Chapter One: Introduction 
1.1 Objective and scope of the project 
Natural herbal medicines have long been used as traditional remedies and food 
supplements for health care in both the Orient and the West. At present, they are applied 
to treat diseases in the empirical ethnomedical therapies and modem medical treatments. 
During the last decade, there is growing interest in the applications of natural herbal 
medicines due to the continual discovery of bioactive components from natural herbs, 
kicreasing numbers of medical reports have documented cases of diseases that could not 
be cured by modem Westem medication were relieved by herbal medicine with 
satisfactory results (Sheehan and Atherton, 1992; Sheehan et aL, 1992). Yet there are 
also numerous case reports about adverse reactions to botanicals (But et aL, 1994, 1996; 
Cosyns et al., 1991，1994; De Smet, 1992; Ivic, 1970; Kane et al., 1995; Tai et al.，1992; 
Vanherweghem et al., 1993). 
One of the major causes of adverse reactions to botanicals is the erroneous 
substitution or accidental contamination of toxic botanicals (But, 1993，1994; But and 
Kan, 1995; De Smet, 1992; Ng et al., 1991). Balkan endemic nephropathy (BEN) in 
Balkan region reported by Ivic (1970) and Chinese herbs nephropathy (CHN) in Belgium 
reported by Vanherweghem et al. (1993) serve to illustrate the possible dangers of these 
causes, ]n the Balkan episode, Ivic (1970) reported the peculiar prevalence ofan endemic 
interstitial nephropathy, also known as the Balkan endemic nephropathy (BEN) in the 
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Balkan Peninsula and the bordering part of Yugoslavia, Romania and Bulgaria. The 
incriminated causal agent was Aristolochia clematitis which contains a potent 
nephrotoxin, aristolochic acid. It was postulated that the seeds ofA. clematitis, a weed in 
wheat fields, contaminated the flour obtained from wheat which was consumed by 
peasants of the epidemic region (Ivic, 1970). ln the Belgian case, problems arose form 
the fact that roots oiStephania tetrandra S. Moore (Menisperaiaceae) were erroneously 
substituted by another more potent herb in the preparation of a slimming regimen. Roots 
of Aristolochia fangchi Y.C. Wu ex Chow et Hwang (Aristolochiaceae), which contains 
aristolochic acid, was incriminated as the etiologic agent in CHN (But, 1993; Cosyns et 
al., 1994; Vanhaelen et al., 1994; Vanherweghem et al., 1993). 
Some researchers have correlated BEN and CHN in clinical, morphological, 
pathological and histoanatomical aspects (Cosyns, 1994; Depierreux, et al., 1994; 
Kabanda et al.，1995). Their peculiar similarity in these aspects has drawn considerable 
attention from medical professions and resulted in the incrimination of the common 
etiologic plant species, Aristolochia (Cosyns et aL, 1994; Kabanda et al., 1995). This 
project was designed to investigate another two Chinese herbs derived from Aristolochia 
species, Guan-mu-tong (Caulis Aristolochiae Manshuriensis) and Ma-dou-ling (Fructus 
Aristolochiae), in order to evaluate the toxicological profile of the Chinese herbs of 
Aristolochia species. Chemical analyses of the two herbal medicines were performed to 
evaluate the aristolochic acid contents. Different aspects of toxicity of the herbs were 
then investigated, including acute, subchronic and reproductive toxicity. Histological 
study was also performed in both acute and subchronic toxicity studies to investigate the 
2 
pathogenesis of the two herbal medicines and compare them with those of BEN and 
CHN. 
1.2 Literature review 
1.2.1 Balkan endemic nephropathy (BEN) 
Balkan endemic nephropathy (BEN), a chronic tubulointerstitial disease, was 
described as unique because of its high prevalence in geographical distribution, clinical 
course and histopathology. The epidemic area is located along tributaries of the River 
Danube, and is highly restricted along the bordering parts of Yugoslavia, Rumania and 
Bulgaria. Since 1956, BEN has been documented in numerous literature (Hall, 1992; 
Hall et al., 1965; Hall and Dammin, 1989; Petrinska-Venkovska, 1965; Polenakovic and 
Stefanovic, 1991; Stefanovic and Polenakovic, 1991; Tanchev et al, 1956). These 
literature revealed that all patients from the epidemic area had a common and peculiar 
pattem of clinical syndromes and renal patho-functional changes. The initial clinical state 
was normal for a certain long period of time except an earlier manifestation of tubular 
proteinuria. The patient became sick only in the late stage of renal failure because of the 
signs of anaemia. Other clinical features included impaired concentration capability of 
kidney and absence of leukuria and hematuria. Li advanced stage, it led to progressive 
renal failure without salt retention or hypertension. The patients fmally died of uremia. 
Autopsy and biopsy study revealed that all patients had a unique tubulo-interstitial lesion 
and fibrosis without significant involvement of the glomeruli or the vasculature. They all 
had a symmetrical reduction in kidney size. Another feature of BEN was its high 
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frequency association with papillary transitional cell carcinoma of the renal pelvis and 
ureter. 
Different etiologic agents were suspected to be the cause of BEN, including lead, 
cadmium, silica, bacteria, viruses, microtoxins, plant toxins, genetic factors and immune 
mechanisms (Hall, 1992; Hall and Dammin, 1989; Polenakovic and Stefanovic, 1991; 
Radonic and Radosevic, 1992; Stefanovic and Polenakovic, 1991). One plausible 
candidate is Aristolochia clematitis L. Ivic (1970) conducted a series of field 
investigation in the epidemic area. He observed that seeds of a weed, A. clematitis, were 
reaped and threshed together with wheat by the peasants. The flour produced was 
therefore contaminated with seed-meal of Aristolochia clematitis which contained the 
potent nephrotoxic agent, aristolochic acid. He further carried out an experimental 
investigation using rabbits fed with the contaminated flour. The pathoanatomical and 
pathohistological examinations revealed similar renal changes characteristic of BEN. 
Nevertheless, another study done on patients of BEN showed that there was no sufficient 
demonstration of the presence of aristolochic acid in the blood, urine and kidney tissue of 
the patients (Hall and Dammin, 1978). 
1.2.2 Chinese herbs nephropathy (CHN) 
Cases of rapidly progressive interstitial renal fibrosis has been reported in 48 
women who have followed a slimming regimen containing Chinese herbs in the same 
clinic in Belgium. The clinic involved has specialized in slimming regimens for more 
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than 15 years. During this period, it applied a formula in the slimming regimen for clients 
without any side-effects reported. However, the formula was changed in 1990. 
Belladonna extract, Han-fang-ji (Radix Stephaniae Tetrandrae, root of Stephania 
tetrandra) powder and Hou-po (Cortex Magnolia Officinalis，bark of Magnolia 
officinalis) powder were added to the slimming preparation. The renal problem was found 
to occur after changing the formula, fe early 1992，two young women who have followed 
the new formula of the slimming regimen were admitted to hospital due to renal failure 
and were started on dialysis immediately. Soon later, another seven women following the 
same slimming regimen were identified to have renal failure O^anherweghem et al.， 
1993). Up till 1994, 71 cases o f t h e progressive interstitial renal fibrosis have been 
identified and 35 of them were on renal replacement therapy (Vanhaelen et al., 1994; 
Vanherweghem, 1994). The clinical findings ofthe patients included tubular proteinuria, 
early and severe anemia, normal blood pressure and aseptic leukocyturia. Autopsy and 
biopsy study on the patients revealed that they had similar morphological and 
pathological patterns: reduction in kidney size, extensive cortical tubular atrophy, loss of 
tubules in the outer cortex, and interstitial fibrosis without glomerular lesions. Their 
renal function deteriorated rapidly at the end stage, leading to terminal renal failure. 
Papillary transitional cell carcinomas in pelviureteric urothelium was also observed 
(Cosyns et al.，1994 a, 1994 b; Vanherweghem, 1994; Vanherweghem et al.，1993). 
Chemical analysis of the capsules of the slimming regimen was performed as 
patients reported to have renal failure. Thin layer chromatographic studies confirmed the 
presence of Hou-po in both the medication and the powder offered by the supplier. 
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However, tetrandrine, which is the characteristic alkaloid of S. tetrandra, could not be 
detected in either the medications or the powder supplied by the Belgian import company, 
feistead，a third unidentified alkaloid-liked chemical which was claimed by 
Vanherweghen et al. (1993) not to be aristolochic acid was detected. At the meantime, 
analysis of the so-called tetrandra powder and the new medications performed in the 
Chinese Medicinal Material Research Center (CMMRC) at The Chinese University of 
Hong Kong showed the presence of aristolochic acid and proved the herb to be A. 
fangchi. It was proposed that Han-fang-ji 漢防己（ o f S, tetrandra) was erroneously 
substituted with Guang-fang-chi 廣防己（ o f A. fangchi) which contains the potent 
nephrotoxic agent, aristolochic acid (But, 1993; Vanhaelen et al., 1994). 
Similar in clinical and histological findings to CHN, another case of rapidly 
progressive interstitial renal fibrosis was reported by Pena et al. (1996). A man was 
discovered to have an end stage renal failure on admission to hospital after a chronic 
intake of a decoction of A. pistolochia for four years. Clinical and histopathological 
findings all showed the marked characteristic ofCHN. 
1.2.3 Aristolochic acid. 
Aristolochic acid (AA) is a yellow, bitter and acidic substance which can be found 
in most Aristolochia species. It refers to a mixture of several related nitrophenanthrene 
derivatives, which include aristolochic acid I (AA-I) and aristolochic acid E (AA-H) as 
the two principle constituents (Figure 1.1). Aristolochic acid I is 3,4-methylenedioxy-8-
6 
methoxy- lO -a i t rophenanthrene- l -carboxyl ic (C17HuNO7, M.W. 341.276), whereas 
aristolochic acid H differs in lacking the methoxy group (Ci6H9NO6. M.W. 311.250). 
Other minor components are aristolochic acid EI, aristolochic acid HIa, aristolochic acid 
p / and aristolochic acid Wa ^)e Smet, 1992). 
HOOC NO, HOOC N0^ 
r ^ ^ Y ^ f<^^YS 
0 ^ ^ > / ^ ^ : : : ^ ^ 0 - C H , 0 ^ ^ / ^ ^ y ^ ^ - H 
H ^ C — 0 k ： ^ H ^ C — 0 ^^^:X 
AA-I AA-n 
Figure 1.1: Structure ofthe aristolochic acid-I (AA-^ and aristolochic acid-H (AA-H) 
AA has attracted much attention since its pharmacological action was first 
discovered. It has once been identified to have antineoplastic activity, thus leading to 
extensive study ofthis substance (Filitis and Massagetov, 1961; Kupchan and Doskotch, 
1962). It was also reported to show anti-inflammatory action. Its anti-inflanunation 
properties had been utilized by pharmaceutical company to prepare medications in 
Germany (Abel and Schimmer, 1983). 
However, as the discovery of its mutagenic O^obisch et al.，1982) and 
carcinogenic properties (Mengs et al.，1982) was reported, all the pharmaceutical 
preparations containing AA were withdrawn and the toxic potency o f A A started to be 
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extensively studied. It was found to have direct mutagenic action in Salmonella 
typhimurium strains in the Ames test (Gotzl and Schimmer, 1993; Pezzuto et al., 1988; 
Robisch et al., 1982; Schmeiser et al., 1984) and in Drosophila tests (Frei et al., 1983). 
Another fmding obtained by Abel and Schimmer (1983) showed that AA increased 
structural chromosome aberrations as well as sister chromatid exchanges in in vitro 
cytogenetic test on human lymphocytes. Its in vivo genotoxic activity in mammals was 
demonstrated by Mengs and Klein (1988) who found that AA was able to increase the 
micronucleated polychromatic erythrocytes in mice. Li addition, Pezzuto et al. (1988) 
revealed the cytostatic potential of AA using cultured Salmonella species cells. Other 
studies on AA have proven its carcinogenic effects in rodents. Subchronic or chronic 
treatment o fAA in rodents showed that it could induce neoplasms in the forestomach and 
other sites depending upon dose and time. Hyperplasia, papillomas and invasive 
squamous cell carcinomas in forestomach with formation of metastases were observed in 
rats at dosages as low as 0.1 mgy'kg i.g. of AA. Hyperplasia, papillomas or carcinomas 
were also found in the transitional epithelium of the renal pelvis and the urinary bladder 
while anaplasia were noted in tubular epithelium of renal cortex (Mengs, 1983, 1988; 
Mengs et al., 1982，1992). Further research on the tumor formation showed that DNA 
adducts formed by AA was found in target and nontarget organs in rodents (Femando et 
al.，1992, 1993; Pfau et al , 1990; Schmeiser et al , 1990). ln addition, its nephrotoxic 
action was revealed in rodents, rabbits and human (Mengs, 1987; Mengs and Stotzem, 
1992，1993; Peters and Hedwall, 1963). Massive tubular necrosis were observed in either 
acute or subchronic toxicity tests in rodents. Proteinuria and glucosuria were reported in 
urinalysis ofthe experimental rodents (Mengs, 1987; Mengs and Stotzem, 1992, 1993). 
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According to Wang and Zheng (1984)，AA was shown to have anti-fertility effect. 
It showed effective antMrnplantation effect in mice at a dosage of 3.7 mg/kg i.g. but not 
in rats (Kong et al, 1986). On the other hand, studies conducted by Che et aL (1984) 
found AA was inactive in fertility-regulating activity ofrats. 
In more recent literature, AA was reported to have inhibitory actions on two 
human innnunodeficiency virus reverse transcriptase (HW-RT) and equine infectious 




refers to the dried stem ofAristolochia manshuriensis Komar. (Family Aristolochiaceae) 
(Figure 1.2). The plant is a large woody climber with grayish green bark. Leaves are 
alternate, heart-shaped and densely hairy on the lower surface. Flowers are tubular and 
bome singly at the axil on short branches. The fruit is a cylindrical capsule with 6 
angularmargins. Seeds are triangular and pale grayish brown in color. F loweringseason 
is in May while fruiting season is in August to September (Chinese Herbal Medicine 
Editing Committee of PRC, 1975; Pharmacopoeia Committee of PRC, 1992; Nanjing 
Pharmacy College, 1976). 
A. manshuriensis is widespread in northern and westem China. It grows in 
shaded, humid places ofvalley O^^anjing Pharmacy College, 1976). 
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Figure 1.2: Guan-mu-tong 
1.2.4.2. Traditional uses 
Guan-mu-tong has a bitter taste and cold property and is noted to be slightly toxic. 
Its traditional uses described in literature include clearing "heat", relieving dysuria, 
promoting diuresis, and stimulating menstrual discharge and the flow ofmilk (lactagogue 
action). It is prescribed for the treatment of such symptoms as ulcers in the mouth and on 
the tongue, dark urine, edema, painful difficult urination, excessive leukorrhea, 
amenorrhea, lack of lactation, and acute arthritis due to "damp heat". The conventional 
dosage is 3 to 9 g (Chang and But, 1986; Nanjing Pharmacy College, 1976; 
Pharmacopoeia Committee ofPRC, 1992). 
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1.2.4.3 Chemical constituents 
The herb contains aristolochic acid I，n, ,EIa, W, IVa, aristoloside, deblic acid, 
magnoflorine, P-sitosterol, oleanolic acid, and hederagenin, etc. (De Smet, 1992; Lou et 
al., 1995; Yang, 1993). 
1.2.4.4 Pharmacological studies 
1.2.4.4.1 Diuretic action 
Litragastric injection of 20 g/kg of a decoction promoted diuretic action in rats. 
Experiments on anesthetized rabbits also showed diuretic action by lg/kg i.v. and the 
urinary excretion of K+，Na+ and C1" ions from the treatment group was significantly 
higher than from that of the control group (Chang and But, 1986). 
1.2.4.4.2 Action on the heart and blood vessels 
Cardiotonic action on the isolated toad or guinea pig heart was exhibited by Guan-
mu-tong decoction. Intravenous injection of 0.5-2 g/kg of the decoction in anesthetized 
dogs or rabbits was reported to elevate the blood pressure which was followed by 
prolonged hypotensive effect (Yang, 1993). 
1.2.4.4.3 Action on smooth muscles 
The decoction was found to excite isolated small intestines of mice but showed 
inhibition on uteri in both non-pregnant and pregnant mice fNanjing Pharmacy College, 
1976). 
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1.2.4.5 Reported adverse cases 
Overdoses of Guan-mu-tong would cause the following toxic effects: dizziness, 
headache, edema, oliguria, and vomiting. Clinical analysis of the patients revealed renal 
pathological changes and acidosis. Extreme cases may die from acute renal failure and 
uremia (Yang, 1993). 
1.2.5 Ma-dou-ling 
1.2.5.1 Plant 
Ma-dou-ling ( 馬 究 鈴 ）’ also known as Fructus Aristolochiae, refers to the 
dried ripe fruit of either Aristolochia contorta Bunge. oxA. debilis Sieb. et Zucc. (Family 
Aristolochiaceae). Both plants are perennial climbing herbs with smooth, supple and 
slender stems; leaves are alternate, petiolate, auriculate. Flowers are irregular, the tube 
being globular with the base inflated but the top narrowed. Fruits of both species are 6-
lobular, 3-7 cm long, 2-4 cm in diameter with numerous compressed seeds in each locule. 
Seeds are thin, obtuse-triangular or fan-shaped, 6-10 mm long, 8-12 mm wide, winged 
and pale brown in color. A. contorta differs from A. debilis in having clusters ofthree to 
ten flowers at the axils of the leaves. 
Flowering season of both species is in July and August while fruiting season is 
from September to October C^^anjing Pharmacy College, 1976; Pharmacopoeia 
Committee ofPRC, 1992; Xu and Xu，1994). 
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A. contorta is mainly widespread in northern China, while A. dehilis in southem 
China. Both species grow along paths, in damp places along stream banks and at the 
edge of woodlands, and in hedges fNanjing Pharmacy College, 1976; Xu and Xu,1994). 
Figure 1.3: Ma-dou-ling 
1.2.5.2 Traditional uses 
Ma-dou-ling has an arid and bitter taste, and is regarded to have a cold property 
and a little toxicity. Its folk uses include clearing "heat" from the lung, and relieving 
cough (antitussive) in bronchitis and pneumonia, being an expectorant in asthma, and 
removing “heat，’ from the large intestine for the treatment of bleeding, swollen and 
painful hemorrhoid. The conventional dosage is 3 to 9 g (Chang and But, 1986; Nanjing 
Pharmacy College, 1976; Pharmacopoeia Committee ofPRC, 1992; Yang, 1993). 
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1.2.5.3 Chemical constituents 
The herb contains aristolochic acid I，E, HIa, D/a, B, 7-hydroxy-aristolochic acid I, 
7-methoxy-aristolochic acid, aristolochine, magnoflorine, P-sitosterol, aristolochinic acid, 
and debilic acid (De Smet, 1992; Yang, 1993). 
1.2.5.4 Clinical and pharmacological studies 
1.2.5.4.1 Clinical action: 
A compound formula containing Ma-dou-ling was effective in the treatment of 
126 cases of chronic bronchitis. After 6 courses oftreatment, 67 cases were satisfactorily 
controlled and 40 cases showed significant improvement (Yang, 1993). Another report 
revealed that a compound formula containing Ma-dou-ling was effective in the treatment 
of94 cases of chronic bronchitis (Chang and But, 1986). 
1.2.5.4.2 Pharmacological studies: 
(i) Antitussive action 
Coughing induced by ammonium hydroxide spraying method in mice and by 
electric stimulation of nerve in cats could be reduced by Ma-dou-ling at 10 gy'kg i.g. and 2 
g/kg i.p., respectively (Wu and Xiong, 1989; Xu and Xu，1994). 
(ii) Expectorant action 
Li an experiment measuring the respiratory mucus secretion of anesthetized 
rabbits, the decoction ofMa-dou-ling was proved to have a weak expectorant action at the 
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dosage of 1 gfkg i.g. (Chang and But, 1986). Another similar study on rats also 
demonstrated a weak expectorant action at the dosage of 4 g/kg (Xu and Xu, 1994). 
(iii) Action on smooth muscles 
In vitro perfusion studies showed that the constriction of isolated bronchus of 
guinea pig induced by acetocholine, histamine, or by pilocarpine could be antagonized by 
1 % extract of Ma-dou-ling. Therefore, the herb is regarded to have anti-asthma action 
(Jiangsu College of New Medicine, 1956; Yang, 1993). Besides, it could cause 
constriction on the peripheral blood vessels, intestinal tracts and uteri of animals (Yang, 
1993). 
(iv) Antifungal action 
Extract of Ma-dou-ling demonstrated antifungal action against Schlenun's 
Dermatomyces favosa, Microsporum audouini and Microsprum lanosum in vitro (Chang 
and But, 1986; Yang, 1993). 
1.2.5.5 Reported adverse cases 
There are few reports on the adverse reaction induced by Ma-dou-ling. Overdose 
is the main reason of the toxic reaction. The symptoms of intoxication are nausea, 
vomiting, abdominal pain, diarrhea, hematuria, proteinuria, dysnea, and hypotension 
(Yang, 1993). A man who had chronic bronchitis took a decoction of 30 g of Ma-dou-
ling and then developed symptoms of nausea, dizziness, tremor, dysnea, and severe 
vomiting with blood. Clinical findings included dehydration and acidosis (Ying, 1983). 
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Besides, a woman was hospitalized due to severe vomiting with dehydration after taking 
a decoction o f l 5 g ofMa-dou-ling for the treatment ofhemorrhoid (Siu, 1989). 
1.3 Chemical analysis 
Analytical methods were necessary to identify the chemical constituents of the 
crude herbal drugs qualitatively and quantitatively before the toxicological studies were 
conducted. Jn the present study, thin layer chromatography (TLC) and high performance 
liquid chromatography (HPLC) were chosen to obtain information of the major chemical 
components of the two herbal drugs of interest. 
1.3.1 Thin layer chromatography 
Thin layer chromatography (TLC) refers to the process of separating the 
constituents of a mixture by permitting a solvent system to flow through a thin layer of 
adsorbent on which different substances are selectively separated into distinct spots or 
bands. The separation of the constituents of the sample mixture depends on the 
interaction of the adsorbent, solvent systems and the solutes in the sample mixture, which 
in tum rely upon the molecular structure of the three components. The individual 
separated spots are detected by visible light or UV visualization, by fluorescence, 
radioactivity or by staining the components with a reagent. A series ofsample standard is 
usually spotted on the same plate for comparison with the sample drug in terms ofrelative 
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migration distance (Rf) value and the distinct color of the spots (Stevenson and Bridges, 
1986; Wagner, 1996). 
The technique of TLC is simple, rapid and efficient for the identification of the 
sample herbal drugs but cannot offer an accurate and rapid quantitative assessment; 
nevertheless it provides a preliminary information for further sophisticated analytical 
procedures of the herbal drugs (Stevenson and Bridges, 1986). Li studying Guan-mu-
tong and Ma-dou-ling, the confirmation of the presence of AA was performed by TLC 
before quantitative analysis. 
1.3.2 High performance liquid chromatography 
High performance liquid chromatography (HPLC) refers to the process of 
separating the constituents of a mixture by pumping the sample with a stream of solvent 
system into a tightly packed column under a high pressure. As in TLC, the separation of 
the constituents depends on the different partition rates between the mobile (the solvent 
system) and stationary phases (the adsorbent), which in tum depend on the nature, 
composition and structure of the components involved. There are different modes of 
HPLC, among which bonded phase chromatograph (BPC) in reverse phase (RP) 
separation is the most widely used. The packing material for this type used is silica 
bonded with alkyl chains of different lengths (C18 being the most common) to offer a 
non-polar surface. The polar nature of solvent system together with the non-polar surface 
of the stationary phase permit differential elution of compounds which are then analyzed 
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by a detector. Ultraviolet, fluorescence, electrochemical, refractive, and conductivity are 
five main types of detectors. The components of the mixture can then be analyzed 
qualitatively and quantitatively with standard calibration (Mcmaster, 1994; Stevenson and 
Bridges, 1986). 
Li the present study, HPLC of reverse phase separation is applied to further 
confirm the identification of AA in the herbal drugs and to quantify the AA contents for 
comparison with the toxic effect observed in the bioassays. 
1.4 Toxicological studies 
Toxicity refers to the harmful effects of substances on living systems. Different 
types of toxicants possess different specific target organ, mode of action and potency. Li 
order to determine the primary and cumulative toxicity of the two herbs, short (acute 
toxicity) and intermediate (subchronic toxicity) term toxicological studies were conducted 
in the present study (Chan et aL, 1992; Lu, 1996). Li addition, a reproductive toxicity test 
was performed to evaluate the harmful effect of the herbs on pregnancy. 
1.4.1 Acute toxicity 
Acute toxicity is defined as “the adverse effects occurring within a short time of 
oral] administration of a single dose of a substance or multiple doses given within 24 
hours" (Organization for Economic Cooperation and Development, 1981). The 
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objectives ofacute toxicity test are to provide indications of the probable target organ and 
the specific toxic effects as well as guidelines for further prolonged studies on the 
substances (Chan et aL, 1992; Lu, 1996). 
There are two types of parameters for the acute toxicity study: lethal and non-
lethal. Median lethal dose ( L D 5 0 ) is one of the lethal parameters. It is defmed as "the 
statistically derived single dose of substance that can be expected to cause death in 50% 
ofthe animals” (Organization for Economic Cooperation and Development, 1981)，and is 
usually used to classify and to compare toxicity among substances. Slopes of the dose-
response curves, time to death, pharmacotoxic signs, and histopathological changes ofthe 
dead animals are other lethal parameters of the acute toxicity. Besides, non-lethal 
parameters should also be taken into consideration in evaluating the toxicity. Those 
animals that survive the test period are subjected to necropsies at the end of the 
observation period. Histopathologic examination of the tissues would be a source of 
understanding the acute toxic effect of the substances for the investigation of the 
reversibility of the toxicants (Chan et al., 1992; Lu, 1996). 
1.4.2 Subchronic toxicity 
Subchronic toxicity refers to '^he adverse effects occurring as a result of the 
repeated daily dosing of a chemical to experimental animals for part (not exceeding 10%) 
of the life span" (Organization for Economic Cooperation and Development, 1981). The 
doses used in subchronic toxicity tests are usually lower than those in the acute toxicity 
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tests. This type of toxicity study at low dose exposure offers information on the 
cumulative effects and dose response relationship of the toxicants (Chan et al., 1992; Lu, 
1996). 
The major indices of subchronic toxicity are the non-lethal ones. Li the present 
study, the following parameters selected were based on the class of the two herbs and the 
expected toxicity for short term risk assessment of the two herbal drugs. 
1.4.2.1 Body weight 
Body weight is a simple sensitive index of toxic effects. It is usually measured 
weekly. 
1.4.2.2 Urinalysis 
Urinalysis is usually included in toxicity studies when renal toxicity is suspected 
to be resulted from the toxicants. Urine volume and urinary protein and glucose were 
determined in this study. Normal kidneys reabsorb most of the water in glomerular 
filtrate. Polyuria or oliguria may indicate impaired renal functions. Almost all glucose in 
the glomerular filtrate are reabsorbed completely in the proximal tubule and thus an 
abnormally high urinary glucose content indicates proximal tubular damage (Zilva and 
Pannall, 1975). Li normal subjects, small amounts of low molecular weight proteins are 
filtered into the glomerular filtrate but nearly all are reabsorbed and catabolized by 
proximal tubule. On the other hand, high molecular weight proteins cannot pass through 
the glomerular wall and should not be found in the glomerular filtrate as well as urine. 
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Thus, proteinuia may be either caused by the failure of proximal tubular reabsorption or 
increased glomerular permeability (Walmsley and White, 1983). An abnormally high 
urinary protein and/or glucose content may indicate proximal tubular or glomerular 
damage (Hodgson and Levi, 1994). 
1.4.2.3 Clinical biochemical analysis 
Biochemical analysis of the plasma or serum is important in evaluating target 
organ toxicity. It provides information about damages on the organ or system function by 
the toxicants. Serum aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT) activities were selected as indicators of liver cell damage (hepatocellular damage) 
in the present study. Transaminases are enzymes that transfer the amino group from an 
amino acid to a keto acid. AST and ALT catalyze the following reactions respectively: 
AST 
Aspartate + a-ketoglutarate ^=r oxaloacetate + glutamate 
ALT 
Alanine + a-ketoglutarate ^=r pyruvate + glutamate 
These enzymes are normally present in the blood in relatively low concentrations. AST is 
a cytoplasmic and mitochondrial isoenzyme and is widely distributed in tissues including 
hepatocytes, skeletal muscle, myocardium, kidney, pancreas and red blood cells. A raised 
activity of serum AST may be due to myocardial disease, liver disease, skeletal muscle 
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disease, haemolysis, renal infarction, or hypothyroidism. ALT exists largely in the 
cytosol. It is specific for hepatocytes. Thus, a raised activity of ALT would be a good 
indicator ofhepatocellular damage (Jones and Berk, 1979; Meites, 1977). 
1.4.2.4 Organ weights 
Gross pathologic examination and organ weights are obtained for test animals 
found dead or during necropsies at the end of the observation period. This provides a 
primary screening of lesion found in the organs which may then be subjected to further 
histopathology study. Lti the present study, organ weights of heart, liver, spleen, lung, 
kidney, stomach, and uterus were measured. 
1.4.2.5 Histopathological change 
Histological examination provides information of any pathological changes 
caused by the toxicants. It reveals the structural changes caused by toxicants. The 
histopathological fmdings, together with the biochemical and physiological data, can 
offer a more complete picture to the toxicity ofthe drugs. 
In this study, conventional light microscopy study was performed on selected 
tissues. Hematoxylin and eosin were used to stain the specimens. 
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1.4.3 Reproductive toxicity 
According to the Chinese literature, Guan-mu-tong and Ma-dou-ling should be 
used with caution in pregnancy or are even contraindicated in pregnancy (Pharmacopoeia 
committee of PRC, 1992; Yang, 1993). Thus, the present study included the 
investigation of effects of the herbal medicines on the female reproductive system during 
pregnancy. The numbers of animals pregnant, normal fetuses and corpus lutea were 
obtained to evaluate the toxic effects of the two herbal medicines on early implantation 
and the development of fetuses. 
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Chapter two: Materials and Methods 
2.1 Materials 
2.1.1 Chinese herbs 
Guan-mu-tong (Caulis Aristolochiae Manshuriensis) and Ma-dou-ling (Fructus 
Aristolochiae) were supplied by a local Chinese herb wholesaler. The following voucher 
specimens were kept at the Museum of the Chinese Medicinal Material Research Center, 
The Chinese University of Hong Kong: 972251 (for Ma-dou-ling) and 972252 (for 
Guan-mu-tong). 
2.1.2 Animals 
Sprague-Dawley female rats (180-220 g), ICR male mice (18-22 g) and ICR 
pregnant mice (30-40 g) were supplied from the Animal House, The Chinese University 
ofHong Kong. They were housed under conditions of 18-20°C, humidity 54-56 % and 
a 12-hour light-dark cycle. They were supplied with standardized pellet food (Supastok 




Standard aristolochic acid (AA) was purchased from Sigma O^.S.A.). It contains 
52 % aristolochic acid I (AA-I) and 41 % aristolochic acid H (AA-H). 
Phosphate buffer of pH 7.5 
Phosphate buffer was prepared by mixing 420 ml 0.1 M disodium hydrogen 
phosphate (26.81 g Na2HPO4.7H2O/L) (Ajax, Australia) and 80 ml 0.1 M potassium 
dihydrogen phosphate (13.61 g KH2PO4y^) (Ajax, Australia). The solution was adjusted 
to pH 7.5 by lM sodium hydroxide or 1 M hydrochloric acid. 
Sodium pyruvate 
For the subchronic toxicity test of Guan-mu-tong, 1.5 mM of sodium pyruvate 
(Sigma, U.S.A.) in phosphate buffer of pH 7.5 was used for the semm aspartate and 
alanine aminotransferase assay. 
DL-Aspartic acid 
Ln subchronic toxicity test of Guan-mu-tong, 0.2 M of DL-aspartic acid, 
monosodium salt (Sigma, U.S.A.) in phosphate buffer of pH 7.5 was used for the serum 
aspartate and alanine aminotransferase assay. 
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fY-KetQglutaric acid 
][n subchronic toxicity test of Guan-mu-tong, 1.8 mM of a-ketoglutaric acid 
(Sigma, U.S.A.) in phosphate buffer of pH 7.5 was used for the serum aspartate 
aminotransferase assay. 
DL-Alanine 
In subchronic toxicity test of Guan-mu-tong, 0.2 M of DL-alanine (Sigma, 
U.S.A.) in phosphate buffer o f p H 7.5 was used for the serum alanine aminotransferase 
assay. 
2,4-DinitroT)henvUivdrazine 
La subchronic toxicity test of Guan-mu-tong, 1 mM of 2,4-dinitrophenyUiydrazine 
(Sigma, U.S.A.) in 1 M hydrochloric acid was used for the serum aspartate and alanine 
aminotransferase assay. 
Enzvme kits 
Kits of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) 
were purchased from Sigma (U.S.A.) for performing the enzyme assays in subchronic 
toxicity study ofMa-dou-ling. 
Diagnostic glucose kits 
Diagnostic glucose kits were purchased from Sigma (U.S.A.) for performing the 
assay in subchronic toxicity test of Guan-mu-tong and Ma-dou-ling. 
26 
10% Buffered formalin, neutral 
10% buffered formalin was prepared by dissolving 6.5 g of di-sodium hydrogen 
phosphate orthophosphate (Ajax, Australia) and 4.0 g sodium di-hydrogen 
orthophosphate (Ajax, Australia) in 900 ml distilled water and then mixed with 100 ml 
commercial formalin (formaldehyde solution, Ajax, Australia) 
2.2 Methods 
2.2.1 Aqueous extraction of the Chinese herbs for acute, subchronic and 
reproductive toxicity tests 
Li each extraction of Guan-mu-tong, 300 g of dry plant material was soaked in 3.3 
liters of distilled water for 1 hour, and then boiled for 1 hour. The extract was then 
filtered by a three-layer cotton cloth. The extract was lyophilized into dry powder for 
storage in a desiccater. A total of31.20 g of dry powder was obtained from 300 g dry 
plant material of Guan-mu-tong, i.e. 10.4 %. The aqueous extract of Guan-mu-tong is 
hereafter referred to as Guan-mu-tong extract. 
In each extraction of Ma-dou-ling, 100 g was soaked in 3 liters of distilled water 
for 1 hour, and then boiled for 1 hour. The extract was then filtered and lyophilized into 
dry powder in the same way as Guan-mu-tong. A total of 12.00 g of dry powder was 
obtained from 100 g dry plant material, i.e. 12.0 %. The extract ofMa-dou-ling hereafter 
referred to as the Ma-dou-ling extract. 
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2.2.2 Chemical analysis 
2.2.2.1 Thin layer chromatography (TLC) 
Ground powder of dry plant material or aqueous extract powder, 0.3 g，was 
refluxed for 30 minutes in 5 ml of absolute ethanol (analytical grade, BDH, England). 
The extract was filtered by Whatman No.l filter paper to separate it fi:om the plant 
residue. The reference mixture, standard aristolochic acid (AA), 1.5 mg was dissolved in 
200 i^l of absolute ethanol. The ethanolic extract of Chinese herbs and standard AA were 
then applied onto a silica gel 60 F254-precoated TLC plates (Merck，Germany). A solvent 
system of toluene (Riedel-de Haen, Germany) - ethyl acetate (Merck, Germany)-
methanol (Lab-Scan, England) - formic acid (Riedel-de Haen, Germany) (in volume ratio 
of 20:10:1:1) was used. The chromatogram was then detected at UV 254 nm (Xu and Xu, 
1994). 
2.2.2.2 High performance liquid chromatography ^HPLC) 
2.2.2.2.1 Sample preparation 
Ground powder of dry plant material or aqueous extract powder, 0.5 g in 25 ml of 
absolute ethanol (analytical grade, BDH, England) was refluxed for 1 hour. The volume 
of filtrate was then adjusted to 25 ml with absolute ethanol. Standard AA, 2.3 mg, was 
dissolved in 5 ml of absolute ethanol, which was then diluted to 20 ml (final 
concentration: 0.115 mg/ml). Aliquot of the extract and standard AA solution was then 
filtered with 0.45 i^m filter ofthe HPLC (Xu and Xu, 1994). 
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2.2.2.2.2 Equipment 
The chromatographic system consisted of a quaternary pump (Quatpump, 
G1322A), an autosampler (ALS, G1313A), a diode array detector (DAD, G1315A) 
(Hewlett Packard series 1100，Germany). Listrument control and data evaluation were 
performed with a Chemstation software (Hewlett Packard, Germany). 
The separation was performed using a thermostatted column compartment C18 
column (250 mm x 4 mm i.d., 5 ^m particle size) (Col. Comp, G1316A) (Hewlett 
Packard, Germany). 
2.2.2.2.3 Reagents 
Methanol (Lab-Scan, England) and acetic acid (Riedel-deHaen, Seelze, Germany) 
were of analytical grade. Water was deionized. 
2.2.2.2.4 Chromatographic conditions 
Analyses were performed using a mobile phase of methanol-water-acetic acid 
(70:29:1). The flow rate was 1 mVmm. The column was kept at room temperature. The 
monitoring wavelengths were UV 254 and315 nm. 
2.2.2.2.5 Peak identification 
Chromatograms were assessed for peak area, retention time and UV scan. 
Identification of significant peaks was based on the relative retention times and UV scan 
with that of standard AA. Quantitative analysis of AA present in the samples were 
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performed by calculating the corresponding peak area of the samples with that of standard 
AA. Standard AA 2, 5, 10，20 or 30 i^l of 0.115 mg/ml was injected to obtain a 
calibration curve (Figure A1). 
2.2.3 Assays for the toxicity 
2.2.3.1 Acute toxicity 
For Guan-mu-tong, ICR male mice o f l 8 - 2 2 g were randomly divided into groups 
of ten as a preliminary test served to screen the dose range. Each mouse was given a 
single dose of 337.72g/kg i.g. (the maximum possible dosage that can be suspended by 
the vehicle) in a volume of 0.2 mV10 g body weight after 4-hour fasting. The mice in the 
control group received the vehicle (distilled water) in an equivalent volume. 
For Ma-dou-ling, ICR male mice ofl8-22 g were randomly divided into groups of 
ten. Each mouse was given a single dose by gavage in a volume of 0.2 mVlO g body 
weight after a 4-hour fasting. The dose ranges tested were 51.2, 64，80 and 100 g/kg i.g. 
The mice in the control group received the vehicle (distilled water). Due to the 
occurrence of advanced autolysis and cannibalism, no readable tissue sections could be 
obtained. An additional batch was used to obtain histopathological information of 
moribund animals. They were then kept under observation for general symptoms of 
toxicity and mortality for 21 days thereafter (Mengs, 1987). 
Body weight of mice for the acute toxicity test of Guan-mu-tong and Ma-dou-ling 
was measured 5 times per week. Autopsies were carried out after 21 days. Kidneys were 
30 
fixed in 10% buffered formalin for histological processing. Dehydration in grading scale 
of ethanol, xylene and embedding in paraffin were performed according to the standard 
procedures. Five micron sections were cut and stained by hematoxylin and eosin (H&E), 
followed by mounting with balsam. Microscopic studies were then followed. Detailed 
procedure of the histological processing was presented in Appendix F. 
2.2.3.2 Subchronic toxicity 
For subchronic toxicity test of Guan-mu-tong, female rats of 180-220 g were 
randomly assigned to groups of ten after a 14-day acclimatization period. Each group was 
given daily doses of 1，3 or 9 g/kg/day in a volume of 8 mVkg by gavage for 3 months. 
Another group received the solvent (distilled water) and served as control. 
For subchronic toxicity test of Ma-dou-ling, female rats of 180-220 g were 
randomly assigned to groups of twenty after a 14-day acclimatization period. Each group 
was given daily doses of2 , 4 or 10 g/kg/day in a volume of 8 mVkg by gavage. Li each 
group, one batch of 10 rats was administrated for 1.5 months while another batch of 10 
rats was dosed for 3 months. Another group of twenty rats received the vehicle (distilled 
water) and served as control. 
During the treatment period for either Guan-mu-tong or Ma-dou-ling, the animals 
were observed for external general symptoms of toxicity and mortality. Body weight was 
measured weekly. Urine samples were collected once a week by placing the rats in 
metabolic cages without food for 24 hours. Urinalysis comprised measurement of urinary 
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volume, color, protein (Lowry method) and glucose (enzymatic test, Sigma glucose 
diagnostics kit). Procedures for the protein and glucose assays were summarized in 
Appendixes A and B, respectively. 
After 3-month treatment for Guan-mu-tong treatment and 1.5- and 3-month for 
Ma-dou-ling treatment, rats were anesthetized and blood samples were collected through 
the dorsal aorta. Serum were isolated from the blood samples for semm aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT) enzyme assays by centrifuge 
at 3000 rpm for 10 minutes. Gross pathological examination were carried out and organ 
weights were measured. Organs were fixed in 10% buffered formalin for histological 
processing and microscopic studies. Procedures for the enzyme assays and histological 
processing were referred to in Appendixes C-F. 
2.2.3.3 Reproductive toxicity 
ICR pregnant mice of30-40 g were supplied by the Animal House at The Chinese 
University of Hong Kong in the first moming when the presence of post-coital plug was 
observed. These mice were considered to be on pregnancy day 1 (PDi). They were 
randomly assigned to control and experimental groups, in groups of ten. The 
experimental groups were administered intragastrically with Guan-mu-tong or Ma-dou-
ling extract by gavage according to their body weight at around 10:00 am. They were 
dosed daily from PDi to PDio. The corresponding control group was given the vehicle 
(distilled water). The mice were autopsied on PDi6 and the number of pregnant animals, 
implantation sites, normal fetuses and corpora lutea were recorded (Kong et al., 1989). 
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2.2.4 Statistical analysis 
All results are expressed as arithmetical means 土 standard errors measurement. 
L D 5 0 values were calculated by means of probit analysis. Analysis of statistically 
significant differences in group comparisons was first performed by means of analysis of 
variance or Kruskal-Wallis analysis of variance. Comparison of the treatment groups 
with the control group was then done by Dunnett's test (Gad and Weil, 1988). 
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Chapter Three: Results 
3.1 Chemical analysis 
3.1.1 Thin Layer Chromatography 
TLC analysis of the crude drug and the aqueous extract of Guan-mu-tong and Ma-
dou-ling confirmed the presence ofAA as compared with the reference standard mixture. 
Two bands were observed as yellowish color under visible light and as dark green 
fluorescence under UV 254 nm, at Rf 0.40 and 0.56 in all samples as well as in the 
reference standard mixture (Figure 3.1 and 3.2). Other bands of different colors and at 
different Rf values in the herbal medicines were also observed. These bands were not 
identified in the present analysis. 
3.1.2 High Performance Liquid Chromatography 
Two peaks were found at relative retention times of 6.343 & 7.788 minutes in 
HPLC chromatogram ofstandard AA detected at UV 254 nm. The first and second peaks 
were identified as AA-I and AA-H respectively because ofthe relative amounts ofthese 
two compounds claimed by the supplier (AA-I: 52%; AA-H: 41%). Peak height and area 
of the first peak were higher and larger than those of the second one, implying greater 
amounts at the first peak (Figure 3.3). UV spectra ofthe two peaks exhibited maximum 
absorbance at about 254 and 315 nm (Figure 3.5). UV 254 nm was selected to perform 
the qualitative and quantitative analysis ofAA in the two herbal medicines. 
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Two peaks matching with relative retention times and UV scan at 254 nm as those 
of reference compound were found in crude drug of Guan-mu-tong and Ma-dou-ling. 
This confirmed the presence of AA-I and AA-H in the two herbal medicines (Figure 3.3 
and 3.5). AA content in the herbal medicines determined from the calibration curve 
(Figure A1) were tabulated in Table 3.1. The crude drug Guan-mu-tong was found to 
have a higher AA content than Ma-dou-ling. 
Aqueous extract of Ma-dou-ling showed two peaks with the same relative 
retention times and UV spectra at 254 nm as that of AA-I '8c AA-H, while aqueous extract 
of Guan-mu-tong showed one peak with similar relative retention time (at about 7.8 
minutes) and same UV spectrum at 254 nm as that of AA-E in the reference compound 
(Figure 3.4 and 3.5). The amount of AA-I was not well measured by the equipment for 
the aqueous extract of Guan-mu-tong because if present it was partially masked by other 
components in the latter extract. The AA H content was about 5-6 times higher in 
aqueous extract ofMa-dou-ling than in the aqueous extract of Guan-mu-tong (Table 3.2). 
The percentage yield of AA extracted from crude drug was much higher in Ma-dou-ling 
than in Guan-mu-tong (Table 3.3). 
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Figure 3.1: The thin layer chromatograph of standard aristolochic acid (AA) 
and ethanolic extract of crude drug Guan-mu-tong (G) and Ma-
dou-ling (M) atUV 254 nm. 
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Figure 3.3: HPLC chromatogram of (a) aristolochic acid; (b) ethanolic extract of crude 
drug Guan-mu-tong; (c) ethanolic extract of crude drug Ma-dou-ling. 
AA-I: aristolochic acid I 
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Figure 3.4: HPLC chromatogram of (a) aristolochic acid; (b) aqueous extract of Guan-
mu-tong; (c) aqueous extract ofMa-dou-ling. 
AA-I: aristolochic acid I 
AA-E: aristolochic acid H 
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Figure 3.5: UV spectra of � aristolochic acid I (AA-I) and (b) aristolochic acid H (AA-
n)-
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Table 3.1: Aristolochic acid content (^ig per gram of crude drug) in ground crude drug of 
Guan-mu-tong and Ma-dou-ling. Values are expressed as arithmetic means 士 
standard errors of triplicates. 
“ Guan-mu-tong Ma-dou-ling 
Aristolochic acid I 296.96tl3.1207 97.58il.558 
Aristolochic acid II 1055.96±14.1834 841.37t8.817 
………fSS"ariidocMc^id \352：93±26^725 938"9^8：2013 
Table 3.2: Aristolochic acid content (^ig per gram of crude dmg) in aqueous extract of 
Guan-mu-tong and Ma-dou-ling. Values are expressed as arithmetic means 土 
standard errors of triplicates. 
“ Guan-mu-tong Ma-dou-ling 
Aristolochic acid I minute amount^ 15.485士0.606 
Aristolochic acid II 66.043±0.6890 444.130±L205 
^cannot be quantified due to interference by other components in HPLC but estimated to be 
lower than 15 p,g/g. 
Table 3.3: The percentage of aristolochic acid extracted into the aqueous extract from the 
crude drugs Guan-mu-tong ^ d Ma-dou-ling. 
Guan-mu-tong Ma-dou-ling 
Aristolochic acid I -^ 15.87 
Aristolochic acid II 6.25 52.79 
a cannot be calculated due to interference by other components in HPLC. 
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3.2 Toxicity of Guan-mu-tong 
3.2.1 Acute toxicity 
After a single dose of 337.72 g/kg i.g. of Guan-mu-tong, all the ten mice were 
sedated. Four mice died within the first six days while the rest of the mice did not have 
any toxic signs and abnormal behavior except sedation. The body weight of the treatment 
group was affected. The control group had a larger gain in body weight (12.50±0.506 g) 
after 21-day observation while the survivors of the treatment group had a relatively 
smaller gain in body weight (3.25+1.03 g for 337.72 g/kg i.g.) (Table 3.4). 
The survivors were sacrificed for autopsies on the twenty-first day after dosing. 
No other lesions was found in the surviving animals. 
42 
Table 3.4: Change in body weight of surviving mice on 21st day after intragastric 
administration a single dose of Guan-mu-tong extract. 
Group Dosage No. of survivors Body weight gain in gram 
(n=10) (gy^ kg i.g.) per no. ofmice (arithmeticmeans± 
dosed standard errors) 
Control - 10/10 12.50±0.506 
Guan-mu-tong extract 337.72 6 / 10 3.25±1.03*** 
*** Significantly different when compared with the control group, p< 0.001. 
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3.2.2 Subchronic toxicity 
During the 3-month subchronic test period, the clinical states of the rats of all the 
treatment groups were normal when compared with that of the control group. 
3.2.2.1 Body weight 
The body weight of all groups increased with time. During the 3-month 
subchronic test period, the body weight of all the treatment groups was not significantly 
different from that of the control group (Figure 3.6). Li comparison with the control 
group, there was no significant reduction in body weight gain in the treatment groups at 
the end of the 3-month subchronic test period (Table 3.5). 
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Figure 3.6: Effect of subchronic treatment of Guan-mu-tong extract on the body 
weight of rats. 
Values are expressed as arithmetic means 土 standard errors. 
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Table 3.5: Licrease in body weight of rats after 3-month subchronic test fed with Guan-
mu-tong extract. Values are expressed as arithmetic means 土 standard errors. 
Group (n=10) Dosage (g/kg i.g.) ^icrease in body weight (g) 
Control 106.2±4.83 





The urine of the treatment groups did not show significant differences from the 
control group in terms of color and amount ofdeposits. 
3.2.2.2.1 Urine volume 
Throughout the 3-month subchronic test, there was no significant changes in 24-
hour total urine volume between the treatment groups and the control group (Figure 3.7). 
3.2.2.2.2 Urinary protein 
Within the 3-month duration, there was intermittently significant differences and 
much fluctuation in the total urinary protein collected in 24 hours between the treatment 
groups and the control group (Figure 3.8). 
3.2.2.2.3 Urinary glucose 
During the 3-month subchronic test, there was no significant differences of 
urinary glucose between the treatment groups and the control group (Figure 3.9). 
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Figure 3.7: Effect ofsubchronic treatment of Guan-mu-tong on the urine volume 
of rats. 
Values are expressed as arithmetic means 土 standard errors. 
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Figure 3.8 : Effect of subchronic treatment of Guan-mu-tong extract on the total 
urinary protein of rats. 
Values are expressed as arithmetic means 土 standard errors. 
* Significantly different when compared with the control group, p<0.05. 
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Figure 3.9: Effect of subchronic treatment of Guan-mu-tong extract on the total 
urinary glucose of rats. 
Values are expressed as arithmetic means 土 standard errors. 
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3.2.2.3 Serum aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT) activities 
After the 3-month subchronic test of the aqueous extract Guan-mu-tong, the 
serum AST and ALT activities in the treatment groups were not significantly different 
from those in the control group (Table 3.6). 
3.2.2.4 Macroscopic and microscopic findings 
Macroscopic examination at the end of 3-month subchronic test of Guan-mu-tong 
did not reveal any lesions in the organs. Further microscopic study on kidney and liver 
showed no morphological changes as compared with the control group. Organ weight of 
the major and selected organs did not show significant differences between the treatment 
groups and the control group (Table 3.7). 
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Table 3.6: Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) 
activities of rats given Guan-mu-tong extract for 3 months. Values are 
expressed as arithmetic means 土 standard errors. 
Treatment group Dosage AST activity ALT activity 
(n=10) (gy'kg i.g.) (SF units/ml) (SF units/ml) 
Control 169.82+17.96 105.82±3.13 
Guan-mu-tong extract 1 176.27±12.78 135.69±6.66 
3 191.74±14.05 123.09±3.38 










































































































































































































































































































































































































































3.2.3 Reproductive toxicity 
The Guan-mu-tong extract exerted an anti-fertility effect in mice at high dosages: 60 
and 90 g/kg i.g. The anti-fertility rates were 40 and 70% respectively. However, mortality 
was also resulted at the highest dosage; 20 % ofthe animals dosed at 90 g/'kg i.g. died (Table 
3.8). 
At autopsies on PDi6, the numbers of implantation sites, normal fetuses, and corpus 
lutea were recorded. No significant differences in these parameters were found between the 





































































































































































































































































































































































































3.3 Toxicity ofMa-dou-ling 
3.3.1 Acute Toxicity 
After a single dose of (51.2-100 g/kg i.g.) the aqueous extract of Ma-dou-ling, 
toxic signs and mortality were observed on the following 21 days. Sedation was observed 
in mice of higher dosage groups immediately after dosing on the first day. However, 
most of them recovered with normal food consumption on the second day. Starting from 
the fourth to sixth days after dosing, there was onset of toxic signs in the morbid mice: 
sedation, piloerection, and tremors of the entire body during locomotion. 
The body weight of the treatment groups was also affected. The control group 
had a larger gain in body weight (12.50土0.506 g) after 21-day observation while the 
survivors of the treatment groups had either smaller gain in body weight (3.14tl.079 for 
51.2 g/kg i.g.) or even loss in body weight (3.80土1.114, 4.67土1.333 and 3.00土1.000 g for 
64, 80 and 100 gy^ kg i.g. respectively) (Table 3.9). The body weight of the survivors in 
higher dosage groups dropped with time and did not regain their initial body weight by 
the end of the experiment even though the initial toxic signs had disappeared and their 
appetite restored again (Figure 3.10). 
For those morbid animals, the body weight dropped rapidly with time several days 
before their death. Further toxic signs such as lack of body warmth, dyspnea, and apathy 
were observed. The mice died within 15 days and the death time depended on the dose. 
The death time was mainly on the third day to sixth day (Table 3.10). The L D 5 0 with 
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93% confidence limit of male mice was found to be 64.74±L22 g/kg i.g. and the dose-
lethality curve was presented in Figure 3.11. 
Autopsies of the survivors in the treatment groups did not show any gross 
abnormality or lesion in the major organs: heart, liver, spleen and lung except the kidney. 
Kidneys of all the treatment groups were pale yellow in color as compared with the dark 
brownish red color in the control group. The cut surface of the cortex was yellow and 
flabby while the pyramids and medulla were brick red in color. 
Microscopic fmdings of the kidneys of the survivors in all the treatment groups 
showed massive tubular atrophy when compared with the control group (Figure 3.12-
3.16). The epithelium of some proximal tubules showed vacuolation while some 
appeared flattened. Large irregular nuclei were found in tubular epithelial cells. The 
lumina oftubules were dilated and filled with desquamation ofmasses ofcell debris and 
protein castes (Figure 3.14-3.16). Distal collecting tubules also showed marked changes 
with flattening ofthe tubules, occasional desquamation, and the presence of castes. The 
cytoplasm of most tubules showed a basophilic color (Figure 3.14-3.16). 
Gross examination and histopathological studies were unable to be performed on 
mice that died intercurrently during the 21-day observation period due to cannibalism and 
advanced autolysis. Therefore, another batch ofmice fed with the same dosages ofthe 
treatment groups were examined. The animals were sacrificed when the moribund signs 
appeared. The renal tissue sections from mice of 64 g/kg group showed massive tubular 
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necrosis with pyknotic nuclei throughout the inner portion of the cortex. The damages 
were predominantly the proximal straight tubules. Li addition, packed glomeruli were 
observed (Figure 3.17 and 3.18). 
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Table 3.9: Change in body weight of surviving mice on 21st day after intragastric 
administration a single dose ofMa-dou-ling extract. 
Group Dosage No. of survivors Body weight gain in gram 
(n=10) (g/kg i.g.) per no. of mice (arithmetic means 士 
dosed standard errors) 
Control 10/10 12.50l0.506 
Ma-dou-ling extract 51.2 7 / 10 3.14±L079*** 
64 5 / 10 -3.80+1.114*** 
80 3 / 10 -4.67±1.333*** 
100 2 / 10 -3.00+1.000*** 
*** Significantly different when compared with the control group, p< 0.001. 
Table 3.10: Death time of mice after intragastric administration ofMa-dou-ling extract. 
Treatment of Total number 
Ma-dou-ling extract Death time after drug administration (day) of animals 
(gy^i.g.) ~ V~~9 l2 f5 f s ~ ~ " ^ died 
5L2 i 2 0 0 0 0 0 3 
64 0 3 1 1 0 0 0 5 
80 0 5 1 0 1 0 0 7 
100 1 7 0 0 0 0 0 8 
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Figure 3.10: Effect ofMa-dou-ling extract on the body weight ofsurviving mice 
after acute treatment. 
ICR mice in groups often were given a single dose ofeither distilled 
water (control group) or one ofthe four different dose levels ofMa-
dou-ling extract (51.2, 64, 80 or 100 gy1cg i.g). 
Values are expressed as arithmetic means 土 standard errors. 
* All the values below are significantly different when compared 
with the control group, p<0.05. 
** All the values below are significantly different when compared 
with the control group, p<0.01. 
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Figure 3.11: Dose-lethality curve ofMa-dou-ling extract on mice. 
ICR mice in groups often were administered with a single dose 
ofdifferent dose levels ofMa-dou-ling extract (51.2-100 g/kg i.g.) 
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Figure 3.12: The renal cortex ofmice in the control group. P, proximaltubules; D, distal 




wmBM Mmmm Figure 3.13: Normal proximal (P) and distal (D) tubules and glomerulus (G) ofthe renal cortex ofmice in the control group. H&E. Magnification x 240.
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_ 
Figure 3.14: The renal cortex of surviving mice showed tubular atrophy (TA), dilated 
tubules (DT) on the 21st day after a single intragastric dose of 100 g/kg of 
Ma-dou-ling extract. H&E. Magnification x 48. 
s^^^^^^^T.g 
國 
Figure 3.15: Flattening (F) and vacuolation (V) oftubules, large irregular nuclei (N), and 
desquamation ofprotein casts (D) in the renal cortex of surviving mice at the 
end ofthe 21-day observation period after a single intragastric dose of 100 
g/kg ofMa-dou-ling extract. H&E. Magnification x 240. 
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Figure 3.16: The renal cortex ofmice showed tubular atrophy (TA), dilated tubules ODT) 
at the end of21-day after a single intragastric dose of 51.2 g/kg ofMa-dou-




Figure 3.17: The kidney of moribund mice showed massive necrosis (MN) of the 
proximal tubules 5 days after a single intragastric dose of 64 g/kg ofMa-
dou-ling extract. H&E. Magnification x 48. 
_ 
Figure 3.18: Massive necrosis (MN) of the proximal tubules of the moribund mice 
sacrificed on the 5th day after a single intragastric dose of 64 gfkg ofMa-
dou-ling extract. H&E. Magnificationx 150. 
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3.3.2 Subchronic toxicity 
The clinical state of rats in the treatment groups given aqueous extract ofMa-dou-
ling extract 4 and 10 g/kg i.g. was not healthy. Piloerection and yellow hair was observed 
in these groups. Diarrhea was noted in the 10 g/kg group since one month after the onset 
of the experiment. 
3.3.2.1 Body weight 
The body weight of rats in the control and treatment groups increased gradually 
during the 3-month subchronic test. However, the rate of increase in body weight was 
much slower in all treatment groups. Since about the 70th day from the onset of the 
experiment, the lOg/^ kg i.g. group showed significant differences in body weight as 
compared with the control group (Figure 3.19). At the end of the 3-month test, gain in 
body weight of the 10 g/kg group was significantly lower than that of the control group 
(Table3.11). 
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Figure 3.19: Effect ofsubchronic treatment ofMa-dou-ling extract on the body 
weight of rats. 
Values are expressed as arithmetic means 土 standard errors. 
* Significantly different when compared with the control group, 
p<0.05. 
** Significantly different when compared with the control group, 
p<0.01. 
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Table 3.11: Licrease in body weight of rats after 3-month subchronic test with 
intragastric administration of Ma-dou-ling extract. Values are expressed 
as arithmetic means 士 standard errors. 
Group (n=10) Dosage (g/kg i.g.) Licrease in body weight (g) 
Control “ 90.6±6.68 
Ma-dou-ling extract 2 70.8±7.02 
4 79.7±4.07 
10 63.4+4.81** 




Since two weeks after the onset of the intragastric administration of Ma-dou-ling 
extract, the urine color of rats in the 10 g/kg group was found to become dark brownish 
with lots of deposits. At a later period of time (one month after the start of the 
experiment), the urine of rats in the 4 g/kg group also showed the same color changes as 
in the 10 gy^ kg group. 
3.3.2.2.1 Urine volume 
During the 3-month subchronic test period, the total urine volume of all treatment 
groups showed an increasing trend. There was a significantly raised total urine volume in 
the 10 g/kg group in comparison with the control group at several time points towards the 
second half of the test period. At the end of 3 months, the total urine volume of all 
treatment groups was significantly elevated (Figure 3.20). 
*> 
3.3.2.2.2 Urinary protein 
The total urinary protein of the 10 g/kg group was significantly higher than that of 
the control group since day 1 of the subchronic test period. It increased with time with a 
fmal mean value of about 150 mg, ahnost 1-fold more than that of the control group 
(about 80 mg). Towards the end of the test, the 4 g/kg group also showed significantly 
raised total urinary protein as compared with the control group (Figure 3.21). 
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3.3.2.2.3 Urinary glucose 
There was significantly elevated total urinary glucose in the 10 g/kg group since 
one week after the onset of the intragastric administration of Ma-dou-ling extract. It 
showed an increasing trend, and reached an amount of about 1.2 mg at the end of the test 
period, three times the amount as in the control group (about 0.4 mg). Li addition, two 
weeks after the start of the experiment, the total urinary glucose in the 2 and 4 g/kg 
groups was significantly higher than that of the control group. Towards the end of the 
subchronic test, a significant increase in total urinary glucose was also found in the 4 g/kg 
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Figure 3.20: Effect ofsubchronic treatment ofMa-dou-ling extract on the urine 
volume of rats. 
Values are expressed as arithmetic means 土 standard errors. 
* Significantly different when compared with the control group, 
p<0.05. 
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Figure 3.21: Effect ofsubchronic treatment ofMa-dou-ling extract on the total 
urinary protein of rats. 
Values are expressed as arithmetic means 土 standard errors. 
* Significantly different when compared with the control group, 
p<0.05. 
*** Significantly different when compared with the control group, 
P<0.001. 
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Figure 3.22: Effect ofsubchronic treatment ofMa-dou-ling extract on the total 
urinary glucose of rats. 
Values are expressed as arithmetic means 土 standard errors. 
* Significantly different when compared with the control group, 
p<0.05. 
** Significantly different when compared with the control group, 
p<0.01. 
*** Significantly different when compared with the control group, 
p<0.001. 
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3.3.2.4 Serum aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT) activities 
At the time of 1.5 and 3 months of subchronic test, the serum AST and ALT 
activities of all treatment groups fed with Ma-dou-ling did not show significant 
differences when compared with those of the control group except the increase in ALT 
activity in the 10 g/kg group (Tables 3.12 and 3.13). 
3.3.2.3 Macroscopic and microscopic findings 
Macroscopic examination of autopsies of rats fed with Ma-dou-ling extract at 1.5 
and 3 months after the onset of the subchronic test revealed no visible lesion in the organs 
except in the stomach. At the mid-point of the 3-month subchronic test, papillomatosis 
was found in the forestomach in the 4 and 10 g/kg groups (Figure 3.23). The papillomas 
formation in the two treatment groups was found to be dose-dependent, with smaller 
nodular papilloma at the ridge between the forestomach and the body in the 4 g/kg group 
(Figure 3.24) and more severe and larger nodular papilloma covering the entire 
forestomach in the 10 g/kg group (Figure 3.25). Necropsies at the end of the 3-month test 
revealed qualitatively and quantitatively more severe lesion in the forestomach in all 
treatment groups (Figure 3.26). The whole forestomach of the 10 g/kg group was covered 
by papillomas. Forestomach ulceration was also noted in this group (Figure 3.27). The 
degree of papillomatosis in the 4 g/kg group was more severe at the end of the test than 
that found after 1.5-month treatment. More conspicuous papillmatosis was observed at 
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the later stage ofthe treatment period (Figure 3.28). The forestomach of the 2 g/kg group 
also showed lesion at the end of the 3-month subchronic treatment. It showed small 
nodules in contrast to the smooth surface in the control group (Figure 3.29 and 3.30). 
Among the vital organ weight recorded at necropsies of rats at both 1.5- and 3-
month after the onset ofthe test, significantly elevated stomach weight was noted in the 4 
and 10 gy'kg groups, ln addition, liver, kidney and lung weight showed increases in the 
treatment groups (Tables 3.14 and 3.15). 
Microscopic examination o f the forestomach showed evidence of hyperkeratosis 
in all the treatment groups after 3-month subchronic treatment. Marked thick keratin 
layers were found in all the treatment groups as compared with the normal thin layers in 
the control group (Figure 31，33, 34 and 37). Li addition to hyperkeratosis, hyperplasia 
and carcinoma were also noted in the forestomach in the 4 and 10 g/kg group (Figure 31-
33). There were irregular nuclei and vacuolated cytoplasm and numerous cell divisions in 
the squamous epithelial layer, which were different from the normal regular pattem in the 
control group (Figure 3.35 and 3.38). Dense leucocyte infiltration and signs of metastasis 
was also found (Figure 3.36). 
Lti comparison with the control group, histological fmdings of the kidney and liver 
of all treatment groups after 1.5- and 3-month of treatment with Ma-dou-ling extract did 
not show evidence of lesion except some cloudy swelling found in cortical tubules of 
some animals in the 10 gyTcg group. 
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Table 3.12: Serum level of aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) activities of rats given Ma-do-ling extract for 
1.5 months. Values are expressed as means 士 standard errors. 
Treatment group Dosage AST activity ALT activity 
(n=10) (gy^ kg i.g.) (SF units/ml) (SF units/ml) 
Control 94.70±9.01 32.10ll.71 
Ma-dou-ling extract 2 87.90±3.77 33.20土1.72 
4 86.10±2.02 34.50tl.04 
10 104.90+10.95 43.40+2.22*** 
*** Significantly different when compared with the control group, p<0.001. 
r 
Table 3.13: Serum level of aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) activities of rats given Ma-do-ling extract for 3 
months. Values are expressed as arithmetic means 士 standard errors. 
Treatment group Dosage AST activity ALT activity 
(n=10) (g/kg i.g.) (SF units/ml) (SF units/ml) 
Control 101.81+5.80 40.91±1.32 
Ma-dou-ling extract 2 117.29±4.54 46.87l2.16 
4 104.41t3.41 46.79±2.15 
10 100.09±6.33 51.8012.23** 
** Significantly different when compared with the control group, p<0.01. 
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Figure 3.23: Rat forestomach ofthe control group and the treatment groups fed with Ma-
dou-ling extract 2 g/kg, 4 g/kg and 10 g/kg for 1.5 months. 
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Figure 3.24: Smaller nodular papilloma at the ridge between the forestomach and the 
body of rat fed with Ma-dou-ling extract 4 g/kg for 1.5 months. 
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•Og^  Figure 3.25: Nodular papilloma covered the entire forestomach without invading the body in ats fed with Ma-dou-ling ext act 10 g/kg for 1.5 months. 78 
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Figure 3.26: Rat forestomach ofthe control group, and the treatment groups fed with Ma-




Figure 3.27: The entire rat forestomach of the treatment group fed with Ma-dou-lmg 
extract 10 gy'kg for 3 months, showing multiple papillmas and ulceration. 
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Figure 3.28: Papillomas ofthe forestomach ofthe treatment groups fed with Ma-dou-lmg 
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Figure 3.29: Small nodules on the forestomach ofthe treatment group fed with Ma-dou-
ling extract 2 gyTkg for 3 months. 
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Figure 3.30: Normal forestomach with smooth surface in the control group fed with 
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Figure 3.31: Forestomach ofthe treatment group fed with Ma-dou-ling extract 10 g/kg 
for 3 months, showing hyperkeratosis (HK) and hyperplasia OHP) in the 























































































































Figure 3.33: Forestomach of the treatment group fed with Ma-dou-ling extract 4 g/kg for 
3 months, showing squamous carcinomas (SC) with hyperkeratosis (HK). 
H&E. Magnification x 48. 謹 M9HP ^ m i i i i i ^ m ^ ' H H ^ ^ ^ ^ H H H ^ ^ ^ ^ ^ ^ ^ P ^ : ^ -」：？^^^丄―—―― ―’ ,¾, Figure 3.34: Forestomach of the treatment group fed with Ma-dou-ling extract 2 g/kg for 3 months, show ng hyp rkeratosis (HK). L，luminal side. H&E.Magnification x 48. 86 
國 
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Figure 3.35: Vacuolated cytoplasm CVC), irregular nuclei (N) and cell divisions (CD) in 
the squamous carcinoma of the treatment group fed with Ma-dou-ling 
extract lOgyTcg group after 3 months. H&E. Magnification x 150. 
Hl^^^: 
^ ^ ^ m 
H^^^p I^ H^S^  Figure 3.36: Metastasis and massive leucocytes infiltration in the forestomach squamous epithelium in the treatment group fed with Ma-dou-ling extract 10 g/kg for3 months. The figur  sh wing aggregate of leucocytes OL) and theme astasizing malignant cells (MC) in t e blo d stream. The m lignantcells w t  rregul r cell size and shape. H&E. Magni i tion x 15 . 87 
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Figure 3.37: Rat forestomach of the control group at the end of the 3-month subchronic 
toxicity test, showing normal squamous epithelial layer (SE) with thin layer 
of keratin (K). M, mucosa; SM, submucosa; ME, muscularis externa. 
H&E. Magnification x 48. 
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Figure 3.38: Rat forestomach of the control group at the end of the 3-month subchronic 
toxicity test, showing normal, regular pattem of the squamous epithelial 
cells (SE) with uniform cell size and shape. K，keratin; M, mucosa; SM, 
submucosa. H&E. Magnificationx 150. 
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3.3.3 Reproductive toxicity 
The Ma-dou-ling extract at 4.15-32 g/kg i.g. showed dose-related anti-fertility 
activity. At higher dosages of 19.2 g/kg i.g. and above, 100% anti-fertility rate was 
observed. Moreover, 40% ofmortality were resulted in the treatment group fed with the 
extract 32 g/kg i.g. (Table 3 • 16). 
At autopsies on PDi6, the numbers of implantation sites, normal fetuses and corpus 
lutea were recorded. No significance differences in these parameters were found between the 



































































































































































































































































































































































































































































































Chapter Four: Discussion 
4.1 Chemical analysis 
4.1.1 Thin layer chromatography 
The two bands observed in the reference mixture of AA should be AA-I and AA-
n based on the information provided by the supplier. Therefore the two herbal medicines 
of Aristolochia species examined in TLC analysis contained these two compounds. 
These herbal medicines were then subjected to a more accurate qualitative and 
quantitative analysis performed by HPLC. 
4.1.2 High performance liquid chromatography 
AA is the active component found in most of the Aristolochia species. HPLC was 
used to determine the AA contents in Guan-mu-tong and Ma-dou-ling qualitatively and 
quantitatively. Among the two herbal medicines studied, the crude drug Guan-mu-tong 
was found to contain a higher total AA content than Ma-dou-ling. 
Since Chinese herbal formulas are traditionally prepared by decocting herbs with 
water, experimental animals in the present toxicity studies were fed with decoction ofthe 
two herbs. Thus, the hot water extracts of Guan-mu-tong and Ma-dou-ling were also 
analyzed for their AA contents. Li the preparation of aqueous extract for the toxicity 
studies on animals, Guan-mu-tong, which was presented in thin slices, was extracted 
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with water in the weight to water volume ratio of 1:11 while Ma-dou-ling was extracted 
in 1:30. The different extraction methods were used because Guan-mu-tong was first 
studied and its volume and water absorption extent was much smaller than that of Ma-
dou-ling. Ma-dou-ling which was studied later had a greater volume and absorbed much 
water during the extraction process，and therefore a larger weight to water volume ratio 
was selected. Thus, a decoction of the same weight to water volume ratio of Guan-mu-
tong (1:11) and Ma-dou-ling (1:30) used in toxicity studies was prepared for HPLC 
analysis. 
The quantitative analysis revealed that the aqueous extract ofMa-dou-ling had a 
higher AA content than that of Guan-mu-tong. About 50 % of the AA content in Ma-
dou-ling was extracted by the aqueous extraction process. On the other hand, a large 
amount of AA in Guan-mu-tong was not extracted and still remained in the crude drug 
after decocting. The possible reason for the lower amount o f A A extracted from Guan-
mu-tong than from Ma-dou-ling is the different surface area of the two herbal drug 
available for extraction. Ma-dou-ling in form of a dry fi:uit was crushed into pieces 
before decocting, while Guan-mu-tong was in form ofthin slices from the supplier. As a 
result, the increased surface area to volume ratio of Ma-dou-ling sample would enable 
AA to dissolve in water, while the smaller surface area to volume ratio ofGuan-mu-tong 
sample would limit the leakage o f A A into water. This difference in the amounts o fAA 
extractable from the two herbs would probably reflect the actual conditions of decocting 
in their normal use in Chinese medicine. 
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4.2 Toxicity of Guan-mu-tong 
4.2.1 Acute toxicity 
Li the present study, the highest possible dosage of Guan-mu-tong extract at 
337.72 gy^ kg i.g. was given to the mice by gavage. After a 21-day observation period, only 
4 of 10 mice dosed died. The dose applied was extremely high but still only 40 % ofthe 
animals died. Thus, the lethal dose of Guan-mu-tong extract could not be definitely 
determined but was higher than 337.72 gfkg i.g. 
4.2.2 Subchronic toxicity 
From the results of subchronic toxicity, the Guan-mu-tong extract did not show 
any significant toxic effect. There was no abnormality in physical observation in the 3 
months ofthe test period. No significant change in body weight was found. Urinalysis 
did not show any effect of Guan-mu-tong extract on the renal functions though there was 
an intermittent increase in urinary protein found in the group fed with Guan-mu-tong 
extract 9 g/kg i.g. As there was difference in random sampling at the beginning of the 
study, it is not clear if the intermittent increase in urinary protein was an indication of 
renal impairment. For the study of serum enzymatic activities, serum AST and ALT 
activities in the treatment groups revealed no changes. Gross and histological 
examination also showed no distinct lesion when compared with the control group. 
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Guan-mu-tong contains nephrotoxic mixture, aristolochic acid (AA). From the 
analysis of TLC and HPLC, the crude drug Guan-mu-tong contains a high AA content. 
However, a relatively large reduction in AA content was found in the Guan-mu-tong 
extract. The reduction may account for the absence of the impairment of renal function, 
which is a known toxic effect ofAA (Mengs and Stotzem, 1992), found in the subchronic 
toxicity. Li conclusion, the Guan-mu-tong extract at dosage up to 9 g/kg did not show 
any toxic effect on female rats in the subchronic toxicity test. 
4.2.3 Reproductive toxicity 
i 1 
In the present study on reproductive toxicity of Guan-mu-tong, an anti-fertility 
activity could be observed only at relatively high dosages (60-90 g/kg i.g.) in mice. Li 
addition, at the highest dosage (90 g/kg i.g.) tested in this study, only 70% anti-fertility 
rate was recorded. 
Guan-mu-tong extract did not reduce the number of implantation sites in all the 
treatment groups. Besides, visual inspection of the fetuses did not show any abnormal 
morphological appearance. 
Although the ethnomedical literature indicated that Guan-mu-tong is 
contraindicated, the present study showed that the antifertility activity of Guan-mu-tong 
extract became obvious only at very high dosages. 
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4.3 Toxicity ofMa-dou-ling 
4.3.1 Acute toxicity 
The gross examination and histopathological fmdings indicated that the primary 
toxic target organ ofMa-dou-ling extract was the kidney. The renal tissues of mice in all 
experimental groups showed tubular impairment of different severity, depending on the 
dosages given. 
Jn the present study, kidneys were obtained from moribund mice several days 
i 
before death. Macroscopically, the cortex was pale yellow in color as compared to the ' 
contrasting brick red color of the medulla. Microscopically, massive tubular necrosis was 
noted in the inner cortex and outer strip of outer medulla. The straight part of the 
I 
j 
proximal tubules was the predominant impaired portion. This specific target portion, 
together with the characteristic macroscopic appearance of the kidney indicated that the 
animals suffered from renal failure due to acute tubular necrosis ODarmady and MacIver, 
1980; Solez, 1993). 
Acute tubular necrosis is a potentially reversible decrease in renal functions 
following injury to the kidneys. The massive tubular necrosis was irreversible in a short 
period oftime (several days) but were able to recover in a long-term period (7-10 days) if 
the animals could survive the challenge. Thus, those animals that could not tolerate the 
injury for the first few days would succumb to death (Wahnsley and White, 1983). Acute 
tubular necrosis consists of four sequential phases: initiation, oliguric/anuric, early 
95 
diuretic, and late diuretic phases. The initiation phase is the period following the toxic 
exposure and refers to the time interval between the injury and the onset of acute renal 
failure. This explains the reasons of the gradual development of toxic signs and the late 
onset of death time in the acute toxicity of Ma-dou-ling extract on mice. The 
oliguric/anuric phase is marked by a reduced urine output containing cellular granular 
casts and rises in blood urea, creatinine, potassium and phosphate levels. This phase 
usually lasts a few days to several weeks. Reparation of the impaired tubules starts in the 
early and late diuretic phases. The early diuretic phase is characterized by excessive 
urinary output because of the impaired concentrating ability of the kidney. Restoration of 
tubular functions and concentrating ability occurs in the late diuretic phase (Williams and ！ 
Mallick, 1994). The process of restoration of renal functions and reparation of tubular 
tissue was demonstrated by the microscopic findings in renal tissues of the surviving mice 
sacrificed on the 21st day after dosing. Cell debris of necrotic cells from proximal 
tubules, flattening and cytoplasmic vacuolation of tubular epithelial cells, and the dilation 
of the tubular lumina were found. Li addition, basophilic cytoplasm and large irregular 
hyperchromatic nuclei were noted in the tubular epithelial cells (Solez, 1993). All these 
changes indicated tubular regeneration and the ongoing process of restoration of renal 
functions in the surviving animals. On the other hand, in severe injury, the moribund 
animals were unable to withstand the intoxication and died during the oliguric/anuric 
phase. 
Since the proximal tubules, especially the straight portion, was found to have 
massive tubular necrosis in the early period of the injury (at about day 5-6 after dosing 
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for the moribund animals), it is possible that this straight portion (known as S3 segment) 
was the main and primary target tissue. One of the main functions of the proximal 
straight tubules is to actively secrete organic ions such as weak acids or bases and 
harmful compounds into the tubular lumen. Transport of organic solutes and the 
metabolism of toxins by tubular cells results in high concentration of toxins and 
generation of toxic metabolites in tubular cells. Therefore, the straight portion is 
particularly susceptible to damages (Swan and Bennett, 1993; Valtin and Schafer, 1995). 
The comparison of the acute toxicity of Ma-dou-ling extract and that of AA 
reported in literature (Mengs, 1987; Mengs and Stotzem, 1993) showed similarity in | 
several aspects particularly on the macroscopic and microscopic fmdings of damage on 
renal tissues. Li addition, experimental animals given either agents had similar delay in 
death time after dosing. Thus, AA may be one of the toxins, if not the only, in Ma-dou-
ling extract causing the toxic effects in acute toxicity test on mice. 
4.3.2 Subchronic toxicity 
During the 3-month subchronic toxicity test with Ma-dou-ling extract, there was a 
reduction in body weight gain in all treatment groups. Certain adverse reactions in the 
treated animals could be the causes of the reduction in body weight gain. Diarrhea was 
found in the group fed with Ma-dou-ling extract 10 g/kg. The Ma-dou-ling extract given 
may be irritant to gastrointestinal tract, causing a faster rate of peristalsis for eliminating 
the toxicants. Thus, the digestion and absorption of ingested food would be hampered. 
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Another cause of reduction in the body weight gain might be the impairment in renal 
function caused by Ma-dou-ling extract. Proteinuria and glucosuria was found in the 
treatment groups. The continual loss of essential body constituents - protein and glucose 
- in urine impeded the growth of the animals. 
The purpose of urinalysis in this study was to examine the effect of Ma-dou-ling 
extract on renal functions. The present study showed that subchronic administration of 
Ma-dou-ling extract caused impaired renal functions in rats, resulting in proteinuria, 
glucosuria and polyuria. The severity demonstrated a dose- and time-dependent 
relationship. 
Glucosuria usually occurs either in diabetes mellitus (systemic disease) or primary 
renal disease. Li cases of untreated diabetes mellitus, plasma glucose level exceeds the 
reabsorbing capacity of the proximal tubule, resulting in the presence of unabsorbed 
glucose in urine. This cause could be rejected as this should be accompanied by the 
symptoms of initial polyuria which was not the cases in this study. Li addition, the 
symptoms of glucosuria should exist much earlier than the proteinuria which would be 
found only in the advanced stage of diabetes mellitus. Yet, proteinuria existed before 
glucosuria in the present study. Another cause of glucosuria is the primary renal 
impairment in which there is a proximal tubular defect in glucose reabsorption. Plasma 
glucose is able to pass through the glomerular wall freely by glomerular ultrafiltration. 
Glucose in the glomerular filtrate is then completely absorbed by the proximal tubule in 
normal functioning kidneys through active transport. Lnpairment in the proximal tubule 
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would result in failure of complete glucose reabsorption (Rose and Rennke, 1994; 
Walmsley and White, 1983). Nonetheless, the histological findings of subchronic 
toxicity test revealed no evident lesion in the proximal tubules, except the local cloudy 
swelling of proximal tubules of several rats in the treatment group fed with Ma-dou-ling 
extract 10 g/kg. Ma-dou-ling extract might have impaired the glucose reabsorption by 
impeding the active carrier transport system for glucose without any cell necrosis and 
atrophy of tubules fValtin and Schafer，1995). 
Besides glucosuria, proteinuria was noted in the urinalysis of the treatment 
groups. The normal protein content in urine is extremely low when compared with that in 
the plasma because proteins of large molecular weight are unable to pass through the 
glomerular wall whereas those of small molecular weight filtered would then be actively 
and almost completely reabsorbed by the proximal tubule. Proteinuria can be traced to 
either glomerular or tubular origins. Proteinuria of glomerular origin is due to an increase 
in the permeability of the injured glomerular wall to the large proteins which are then 
excreted. On the other hand, tubular proteinuria relates to the impairment of proximal 
tubule which results in the failure of reabsorption and excretion of the low molecular 
weight proteins (Rose and Rennke, 1994). The exact type of the proteinuria caused by 
Ma-dou-ling was not determined because the Folin-Lowry protein assay performed in the 
present study was unable to differentiate the two causes OPesce and First, 1979). Jn 
addition, the histological findings did not reveal any lesion in these two parts, except 
some focal cloudy swelling of the cortical proximal tubules found in a few animals of the 
10 gy'kg group. Therefore, the exact etiology of proteinuria caused by Ma-dou-ling extract 
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was not obvious. Nonetheless, the fmdings of glucosuria might suggest a greater 
possibility of proteinuria of tubular origin, ln addition, the result of acute toxicity also 
showed damage in renal part of mice treated by Ma-dou-ling - the proximal tubules. Ma-
dou-ling extract may probably impaired this particular part, causing the failure of 
reabsorption of glucose and protein. 
Originally, the purpose of measuring the urine volume was to calculate the total 
amount of urinary protein and glucose. The present study also showed an increasing 
trend of urine volume in all the treatment groups, depending on dose and duration of the 
treatment. Significant polyuria was noted since 40 days after the onset of the oral 
administration of Ma-dou-ling extract. This showed there was an impairment in the 
concentration ability ofthe kidney. 
From the pathological fmdings in the acute toxicity test, the impairment of renal 
functions by Ma-dou-ling extract in the subchronic toxicity test might be primarily due to 
damage of the proximal tubules. As mentioned before, the proximal tubules are 
responsible for the active secretion and metabolism of organic ions and harmfiil 
compounds. Therefore, the proximal tubules are vuhierable to the high concentration of 
toxins and their metabolites (Swan and Bennett, 1993; Valtin and Schafer, 1995). It 
might be the target site of the toxicants and their active metabolites in Ma-dou-ling 
extract. 
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Li comparison with the renal impairment by AA, there was similarity in the results 
of the urinalysis. Proteinuria, glucosuria, and impaired urinary concentrating ability were 
resulted from the subchronic toxicity of AA (Mengs and Stotzem, 1992; Peters and 
Hedwall, 1963) and Ma-dou-ling extract. However, no evident necrotic lesion was found 
in the cortical renal tubules of rats fed with Ma-dou-ling extract, whereas the damage 
prominent in rats intoxicated by 25 mg/kg i.g. but not by 5 mg/kg i.g. AA 1 month after 
subchronic intragastric administration (Mengs and Stotzem, 1992). Another investigation 
on subchronic toxicity of AA by Mengs et al. (1982) did not demonstrate any impairment 
of renal function and lesion in the renal cortex at a lower dosage of 10 mg/kg i.g. This 
suggests that a higher dosage or longer duration of treatment of Ma-dou-ling extract 
might be required to result in the same histological findings. 
As compared with the Chinese herbal nephropathy (CHN) and Balkan endemic 
nephropathy (BEN), the clinical results of urinary glucose and protein contents in rats fed 
with the Ma-dou-ling extract did show an elevated level. Yet, reduced kidney size and 
interstitial renal fibrosis, the characteristics of CHN and BEN，were not observed in the 
present subchronic administration ofMa-dou-ling extract on experimental rats. 
Li addition to impairment in renal functions, subchronic administration of Ma-
dou-ling extract induced the development of squamous cell carcinoma in the forestomach. 
Lti rats, the stomach consists of two parts: the forestomach (non-glandular portion) and the 
body (glandular portion). The luminal surface of the forestomach is the keratinized 
stratified squamous epithelium, whereas the body contains the modified columnar 
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epithelium (Craddock, 1993). The present study revealed that Ma-dou-ling extract 
induced papillomas and carcinomas in the forestomach without invasion to the stomach 
body. This indicated the carcinogenic action of Ma-dou-ling extract was specific to the 
region of the forestomach. 
Hyperkeratosis, hyperplasia, carcinoma and metastasis were the histological 
findings in the forestomach of the treatment groups. The extent of these pathological 
changes in the different treatment groups depended on dosage and duration of treatment. 
Such changes appeared to follow the sequence ofhistological changes in esophageal and 
forestomach cancer formation (Craddock, 1993，Mengs, 1983), starting with normal 
stage, and then advancing to mild hyperplasia with hyperkeratosis, marked hyperplasia 
with hyperkeratosis, early carcinoma in situ, and fmally invasive carcinoma. Therefore, 
after 3-month subchronic intragastric administration of Ma-dou-ling extract, only mild 
hyperplasia with hyperkeratosis were found in the small dosage group (2 g/kg i.g.) 
whereas marked hyperplasia and invasive carcinoma were noted in the medium (4 g/kg 
i.g.) and higher (10 gy^g i.g.) dosage groups. It would be plausible to envisage the 
development of carcinoma in the 2 /kg group if the present study had been continued for a 
longer period of time. 
The fmdings of carcinomas formation in the treatment groups with dosage as low 
as 4 g/kg i.g. after treatment for 3 months indicated that the Ma-dou-ling extract 
contained a potent carcinogenic substance. Aristolochic acid (AA) in the Ma-dou-ling 
extract was probably, one if not the only, cause for the forestomach carcinomas. Findings 
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ofthe investigation by Mengs (1983) and Mengs et al. (1982) on the carcinogenic action 
and histopathogenesis of rat forestomach carcinoma induced by AA bear much 
similarities to the macroscopic and microscopic changes in rats fed with the Ma-dou-ling 
extract. 
Measurement ofthe serum ASTand ALT activities was used in the present study 
to investigate the liver lesion. As mentioned in Section 1.4.2.3, elevated serum enzyme 
activities indicated an increase in the corresponding serum enzyme level. This in tum 
indicated there was damage ofthe organ to which the enzyme is specific. Li the present 
study, the serum ALT activities in the 10 g/kg group was elevated afterl.5 and 3 months 
of subchronic treatment with the Ma-dou-ling extract, while no increase was noted in the 
serum AST activities. The raised serum ALT activities indicated an increase in the 
amounts of ALT level in the bloodstream. As ALT is specific to the liver, this result 
showed evidence of liver damage in the 10 g/kg group. On the other hand, there was no 
significant elevation in the serum AST activities, which showed no indication of 
increasing serum AST level. The two transaminase, ALT and AST, have different 
intracellular localization, with ALT present only in cytosol while AST in both cytosol and 
mitochondria. With mild hepatocelluar damage, ALT levels are higher than AST while 
the elevation ofthe latter was found in more severe cellular necrosis due to the release of 
mitochondrial enzymes (Walmsley and White, 1983; Zilva and Panail, 1975). Thus, 
there was mild hepatocellular damage in rats ofthe 10 g/kg group after 1.5- and 3-month 
subchronic treatment with the Ma-dou-ling extract. 
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Histological study further provided information about the degree ofhepatic lesion. 
No hepatocellular necrosis was found in the microscopic examination in all the treatment 
groups. The absence of hepatocellular necrosis could well explain the sole elevation in 
ALT level but not in AST level. The hepatic damage by the Ma-dou-ling extract was not 
severe to the extent of cell necrosis to cause a release of mitochondrial AST. Therefore 
no change in serum AST level was noted. For the elevation of serum ALT, this could be 
accounted for by their leakage from hepatocytes. Subjected to toxin, membrane 
permeability of the hepatocytes will be increased and thus the cytosol ALT leaks out to 
the serum while the hepatocytes are intact. (H0rder and WiUdnson, 1979; Jones and Berk, 
1979). 
Dark brown urine color found in the groups fed with Ma-dou-ling extract 4 and 10 
g/kg also provided an indication of hepatocellular damage, ln urine of normal subjects, 
little urobilinogen is excreted by the kidney. The urobilinogen is oxidized to urobilin 
which is a brown pigment. For those having haemolysis or hepatocellular diseases, an 
increased urobilinogen content will be found in their urine, which will then become deep 
orange-brown (Walmsley and White, 1983). The deep orange-brown urinary color in the 
groups fed with Ma-dou-ling extract 4 and 10 g/kg in this experiment might be due to the 
hepatocellular damage when taking the result of serum AST assay into consideration. As 
mentioned before, haemolysis can be indicated by the elevated serum AST lever. Thus, 
the absence of raised serum AST level excluded the cause ofhaemolysis. 
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From the results of the clinical biochemical test (AST and ALT), histological 
fmdings and observation ofurine color, it could be concluded that the liver ofthe 10 g/kg 
group was damaged to an extent of leaking ALT into the bloodstream and causing the 
impairment of re-excretion of the urobilinogen without any severe hepatocellular 
necrosis. 
In addition to liver, AST is also found in skeletal and cardiac muscles, pancreas as 
well as erythrocytes. Thus, absence of elevation of serum AST level also suggested no 
damage to these tissues. 
4.3.3 Reproductive toxicity 
Ma-dou-ling extract showed a dose-dependent anti-fertility effect on mice. It 
reduced the number of pregnant mice at a dosage as low as 4.15 g/kg i.g. and produced a 
100 % anti-fertility effect at 19.2 g/kg i.g. and above. This indicated that an active 
constituent was present in Ma-dou-ling extract. Yet, lethality of mice were observed at 
32 g/kg i.g. 
Ma-dou-ling extract did not reduce the number of implantation sites in pregnant 
mice. Li addition, the extract also did not cause any malformation offetus. 
In the traditional Chinese medical literature, it was stated that Ma-dou-ling had to 
be used with caution for pregnant women. Li the present study, Ma-dou-ling extract 
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indeed exerted anti-fertility effect at a relatively low dosage (4.15 g/kg i.g.) and could 
reach 100% activity at 19.2 g/kg i.g. The study confirmed the caution made in traditional 
Chinese medicine. 
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Chapter Five: Conclusion 
From the results of acute, subchronic and reproductive toxicity studies, the Ma-
dou-ling extract showed a higher toxicity than the Guan-mu-tong extract. 
In acute toxicity test, even the highest possible dosage of Guan-mu-tong extract 
did not result in lethality of all the mice dosed (337.72 gy^ kg i.g.). The lethal dose thus 
could not be clearly defined. The 3-month subchronic toxicity test of Guan-mu-tong 
extract did not show any toxic effects on the female rats. For rats treated with Guan-mu-
tong extract, there was no reduction in body weight gain, no elevated urinary volume, 
glucose content, and no raised serum AST and ALT activities except some fluctuations in 
the urinary protein content. In addition, gross fmdings at autopsies did not reveal any 
lesion in major organs. Histopathological study on the liver and kidney did not show any 
damages by Guan-mu-tong extract. These fmdings showed that Guan-mu-tong extract 
had no or only a very mild renal toxic effects on female rats. In the reproductive toxicity 
test, Guan-mu-tong extract exerted an anti-fertility effect on mice at fairly high dosages, 
at which level mortality was also resulted. 
On the contrary, a single dose of Ma-dou-ling extract (51.2-100 g/kg i.g.) led to 
mortality of mice in the acute toxicity test. The LD50 with confidence limit of 95 % was 
64.74tl.22 g/kg i.g. Animals died mainly on the third to sixth day after dosing. In 
addition, there was a reduction in body weight of the moribund and surviving animals. 
Gross and histopathological examination revealed that the kidney was the target organ of 
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the toxicants. The clinical observation, body weight together with the gross and 
histopathological findings showed that the animals probably died due to acute renal 
failure. This may indicate that a single dose of the Ma-dou-ling extract caused lethality in 
animals by impairing the renal functions. The subchronic test of the Ma-dou-ling extract 
showed toxic effects on the female rats even at the lowest dosage in this study. There 
was a reduction in body weight gain. Elevated urinary volume, glucose and protein 
indicated impairment of renal function by the Ma-dou-ling extract. Raised serum ALT 
activities also reflected the damage caused by the Ma-dou-ling extract to liver tissues. 
Besides, papilloma and carcinoma in stomach showed that the Ma-dou-ling extract 
contained carcinogens. The findings from the subchronic study proved that Ma-dou-ling 
is a potent Chinese herbal drug and would be harmful if consumed for prolonged period 
of time. For the reproductive toxicity test, the Ma-dou-ling extract showed a dose-
dependent reduction in fertility rate at relatively lower dosages. The result showed that 
Ma-dou-ling should be prescribed in caution for pregnant women. 
]n comparison with AA, the Ma-dou-ling extract showed a similar pattem of toxic 
effects in acute, subchronic and reproductive toxicity tests. This implies that AA would 
be one of main active constituents in Ma-dou-ling contributing the toxic effects in the 
toxicity studies. This was further supported by the quantitative fmdings from HPLC 
analysis which showed the Ma-dou-ling extract to have a higher AA content than Guan-
mu-tong extract and thus the toxicity tests of the latter showed a relative lower harmful 
effects. However, it should be emphasized that the result only revealed the toxicity of 
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the aqueous extract of the two herbal drugs but not the crude drug as the result of HPLC 
showed that crude drug Guan-mu-tong had a relatively higher AA content. 
Jn the 3-month subchronic test of the Ma-dou-ling and Guan-mu-tong extracts on 
rats did not resulted in renal interstitial fibrosis which is the characteristic fmding in both 
BEN and CHN. A chronic toxicity test, 9- or 12-month period, might be required to 
investigate the long-term effect of the two Chinese herbs ofAristolochia species. 
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Figure Al: Calibration curves ofaristolochic acid I (AA-I) and II (AA-II) using profile 
ofHPLC and UV 254 nm. 
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Appendix A: Procedure on determining the total urinary protein. 
1 • Lnto a test tube, pipet 20 i^l urine sample and 180 |il distilled water. 
2. Add different volumes of the bovine serum albumin (BSA) (Sigma, USA) solution 
and distilled water indicated in the following table into test tubes for the preparation 
of standard curve: 
^ S A Concentration (mg/ml) 0 0.2 0.4 0.6 0.8 1 
Volume of 1 mg/ml ofBSA (^il) 0 40 80 120 160 200 
Volume ofdistilled water (^il) 200 160 120 80 40 0 
3. Add 2 ml of solution I* into each test tube. 
4. Shake gently and wait for 10 minutes. 
5. Add 0.2 ml ofsolution H** into each test tube. 
6. Shake gently and then leave in a 37�C water bath for 30 minutes. 
7. Read and record absorbance at 650 nm. 
* Solution I: Reagent A:B:C = 1:1:100 (fresWy prepared) where 
Reagent A: 1% cupric sulfate (CuSO4.5H2O) (Sigma, USA) 
Reagent B: 2% sodium potassium tartrate (C4H4O6KNa.4H2O) (Sigma, USA) 
Reagent C: 2% sodium carbonate QS[a2C03.10H20) (Peking Analytical Reagent, 
China) in 0.1 M sodium hydroxide(BDH, England) 
**Solution n： Folin-Ciocalters phenol reagent (dilute one time with distilled water before 




i 0.8 - ^ 
S / 
CO - Z 
句 ® x 
8 0 . 6 - X 
I - / 
I 0 . 4 - T 
- ^ 
0.2 - y ^ 
0 . 0 - f f ^ ~ ~ I 1 1 1 1 1 1 1 ‘ I 
0 40 80 120 160 200 
Protein concentration (mg/20 ul) 
Figure A2: Calibration curve of total urinary protein. 
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Appendix B: Procedure on determining the total urinary glucose using 
Sigma diagnostic kits. 
1. Prepare 1，3, 5, 7 and 9 ^ig/100^1 by serial dilution with 0.1% benzoic acid from 100 
mgML p-glucose standard solution. 
2. Add 100 ^1 urine sample or standard solution into a test tube. 
3. Add 2.5 ml ofcolor-enzyme reagent solution* into each test tube. 
4. Shake gently and then leave in a 37°C water bath for 30 minutes. 
5. Read and record absorbance at 450 nm. 
* Color-enzyme reagent solution was then prepared by combining 100 ml of enzyme 
solution and 1.6 ml of color regent solution where 
1) enzyme solution was prepared by dissolving contents of 1 capsule of 
enzymes which contained peroxidase and glucose oxidase to 100 ml 
distilled water and 
2) color reagent solution was prepared by reconstituting one vial of o-
Dianisidine Dihydrochloride with 20 ml distilled water. Aliquots of 
1.6 ml were kept in eppendorf tube storing at 4°C. 
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Figure A3: Calibration curve oftotal urinary glucose. 
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Appendix C: Procedure on determining the activity of aspartate 
aminotransferase (AST). 
1. Add 0.5 ml substrate solution containing 0.2 M of DL-aspartate and 1.8 mM of a-
ketoglutaric acid, in phosphate buffer o fpH 7.5, into a test tube and place in a 37�C 
water bath to warm. 
2. Add 0.1 ml serum. Shake gently and leave in the water bath. 
3. Add 0.5 ml Sigma Color Reagent which contains 1 mM of 2,4-dinitrophenlhydrazine 
(DNP) in 1 M hydrochloric acid. Shake gently and leave at room temperature for 20 
minutes. 
4. Add 5 ml 0.4 M sodium hydroxide. Mix by inversion. 
5. Wait at least for 5 minutes. Read and record absorbance at 505 nm using water as 
reference. 
6. Determine AST activity from the calibration curve (Figure A4 and A5). 
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Appendix D: Procedure on determining the activity of alanine 
aminotransferase (ALT). 
1. Add 0.5 ml substrate solution containing 0.2 M of DL-alanine and 1.8 mM of a-
ketoglutaric acid, in phosphate buffer o fpH 7.5, into a test tube and place in a 37°C 
water bath to warm. 
2. Add 0.1 ml serum. Shake gently and leave in water bath. 
3. Add 0.5 ml Sigma Color Reagent which contains 1 mM of 2,4-dinitrophenUiydrazine 
(DNP) in 1 M hydrochloric acid. Shake gently and leave at room temperature for 20 
minutes. 
4. Add 5 ml 0.4 M sodium hydroxide. Mix by inversion. 
5. Wait at least for 5 minutes. Read and record absorbance at 505 nm using water as 
reference. 
6. Determine ALT activity from the calibration curve (Figure A4 and A5). 
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Appendix E: Procedure for preparing a calibration curve for the 
measurement of aspartate aminotransferase (AST) & 
alanine aminotransferase (ALT) activities. 
1. Add different volumes of the solutions indicated in the following table into test tubes: 
Tube *Calibration **Substrate Distilled Serum AST Serum ALT 
no. standard solution (ml) water activity activity 
( ^ (ml) (SF Units/ml) (SF Units/ml) 
~~1 0 0 ^ 0 0 0 
2 0.05 0.45 0.1 20 23 
3 0.1 0.4 0.1 55 50 
4 0.15 0.35 0.1 95 83 
5 0.2 0.3 0.1 148 125 
6 0 ^ 0 ^ y ^ -
* Calibration standard solution is 1.5 mM of sodium pyruvate，in phosphate buffer of pH 
7.5. 
** Substrate solution containing 0.2 M of DL-aspartate and 1.8 mM of a-ketoglutaric 
acid for AST and substrate solution containing 0.2 M ofDL-alanine and 1.8 mM of a-
ketoglutaric acid for ALT. 
2. Add 0.5 ml color reagent to each tube. Shake gently and leave at room temperature 
for 20 minutes. 
3. Add 5 ml 0.4 M sodium hydroxide solution to each tube and mix by inversion. 
4. Wait at least 5 minutes. 
5. Read and record the absorbance at wavelength 505 nm using water as reference. 
6. Plot AST and ALT calibration curves of absorbance values versus the corresponding 
units of AST and ALT respectively (Figure A4 and A5). 
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Figure A4: Calibration curves of aspartic aminotransferase (AST) and alanine 
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Figure A5: Calibration curves ofaspartic aminotransferase (AST) and alanine 
aminotransferase (ALT) activities for subchronic toxicity test ofMa-
dou-ling extract. 
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Appendix F: Procedure on tissue preparation for light microscopic 
study. 
Procedure Reagent Time 
Fixing 10 % buffered formalin >24hours 
Processing Dehydration 50 % Ethanol 2hr. 
70 % Ethanol 2 hr. 
85 % Ethanol 2 hr. 
95 % Ethanol 1 hr. 
100 % Ethanol 1 hr. 
100 % Ethanol 1 hr. 
Clearing Xylene:Ethanol (1:1) 30 min. 
Xylene 30 min. 
Xylene 30min. 
Lifiltration ParafFm wax 1 hr. 
Paraffin wax 1 hr. 
Paraffm wax C^acuum 30 min. 
aspiration) 
Embedding Paraffm wax (allow to cool -
and trim) 
Sectioning Section at 5 ^m thick, adhere on slides and dry on warm plate 
ovemight. 
Staining Dewax Xylene 5 min. 
Xylene 5 min. 
Hydration 100 % Ethanol 1 min. 
95 % Ethanol 1 min. 
70 % Ethanol 1 min. 
50 % Ethanol 1 min. 
30 % Ethanol 1 min. 
nmning tap water 1 min. 
Staining Mayer's Hematoxylin 10 min. 
running tap water 1 min. 
1 % acid alcohol ~5 sec. 
nmning tap water 1 min. 
Scott's tap water 1 min. 
running tap water 1 min. 
0.5 % aqueous eosin 4 min. 
running tap water 1 min. 
Dehydration 70 % Ethanol � 5 sec. 
95 % Ethanol � 5 sec. 
100 % Ethanol lmin. 
100 % Ethanol 2min. 
Xylene :Ethanol (1:1) 2 min. 
Xylene 2 min. 
Xylene 2 min. 
Mounting Canada Balsam |_^  
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